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Chapter 1 
INTRODUCTION 
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Although various magnesium salts were used as cathartics already in the Renaissance 
in Italy, it lasted till the 1920s that magnesium first was shown to be essential for 
animals [1]. Clinical magnesium depletion was first described in 1934 in a small 
number of patients with various underlying diseases [2]. The clinical features may vary 
widely and depends on duration and gravity of the depletion. 
The development of atomic absorption spectrophotometry in the 1950s and the 
numerous studies performed thereafter, accumulated to the conclusion that 
magnesium is not a trace element but the second most abundant intracellular cation. 
The total magnesium content of a human adult is about 1 mol elementary magnesium 
(24 grams), of which 50-60% is located in the bone and the rest distributed equally 
between muscle and other soft tissues [3]. 
DISTRIBUTION OF MAGNESIUM IN THE BODY 
Serum 
Only 1% of the total body magnesium is present in serum with a normal serum 
magnesium level of 0.70-1.1 mmol/1· Younger persons tent towards higher serum 
magnesium levels (Fig. 1). In serum about 34% of the magnesium content is bound to 
proteins, 11% complexed mainly to phosphates and citrates and 55% is present in the 
free ionized form [3]. 
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Figure 1. Serum magnesium concentration versus age; 1: < 2 years, 2:2-10 years, 3: 10 - 20 years, 4: 
20 - 40 years, 5: > 40 years. 
Bone 
Magnesium ions are not incorporated directly into the apatite mineral structure of 
bone, but are concentrated in the hydration shell around each hydroxyapatite crystal. 
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From this surface-bound ion complex magnesium can be released when magnesium 
intake is restricted [4]. The extent of this labile reserve varies with age and falls from 
about 30% of the total bone magnesium in young rats to 17% in adult animals [5]. In 
human bone 30% of the total magnesium is present in a surface limited pool, either 
dissolved in the hydration shell or absorbed on the surface of the hydroxyapatite 
crystals. This part of the bone magnesium is fairly rapidly exchangeable, whereas the 
remaining 70% forms an integral part of the bone crystal [6]. Trabecular bone 
contains more magnesium than cortical bone [6]. Alfrey et al. [7] claimed that there 
existed a highly significant correlation between levels of serum and bone magnesium 
both decreasing during magnesium depletion. 
Muscle 
In skeletal muscle fibres magnesium may bind to several proteins, such as troponin, 
calmodulin, parvalbumin, myosin and ATP-ases which are of great importance for an 
adequate muscle function [8]. Within muscle cells, like other nucleated cells, 
magnesium is not distributed homogeneously in the cell but has the highest 
concentrations in mitochondria and sarcoplasmatic reticulum. Most of total 
intracellular magnesium, concentration 3-6 т т о І Д is bound to proteins and only 0.6 
mmol/1 is present in the free ionized form [9]. In contrast to rats and dogs where no 
consistent significant decrease was noticed [10,11], a variable amount of the human 
skeletal-muscle magnesium can be lost with an average of 15%, equivalent to 0.55-
0.99 mmol/kg [11]. The largest losses (40%) were noticed in children with protein-
calorie malnutrition [12]. 
Mononuclear cells 
In 1969 Baron and Ahmed [13] advocated leucocytes for the measurement of 
intracellular cations. Recently Elin [14] reviewed 10 years of human mononuclear 
blood cells magnesium measurements and concluded that mononuclear magnesium 
measurement is helpful in the assessment of the magnesium status of the patient. A 
significant correlation for magnesium in mononuclear cells and muscle was shown [15] 
and also for magnesium and potassium in mononuclear cells [16,17]. Normal values 
(mean ± 1 sd) for mononuclear magnesium are: 3.48 ± 1.28 fmol/cell (equivalent to 
84 ± 31 fg/cell) or 53.3 ± 12.5 Mmol/g protein (equivalent to 1.28 ± 0.30 Mg/mg 
protein) [18]. 
Red blood cells 
After Archer et al. [19] presented a method for the measurement of erythrocyte 
magnesium content, many reports were published. Normal values in adults are 1.69 -
2.99 mmol/l red blood cells [19]. Erythrocyte magnesium decreases with the age of the 
red blood cells and in magnesium deprivation erythrocytes have a shorter survival. 
The usefulness of red blood cell magnesium for clinical medicine remains unclear [20]. 
It is discussed later, highlighted by our own results. 
Intracellular magnesium 
As a necessary cofactor in more than 200 hundred enzymes, intracellular magnesium 
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influences a wide range of cellular functions such as glycolysis, respiration, protein-, 
DNA-, RNA-synthesis and transmembrane transport of other ions for example Na+ 
and Ca2+ [21,22]. Modulation of calcium channel activity by magnesium in ventricular 
cells was found by Agus et al. [23]. 
Intracellular magnesium is compartmentalized and most of the magnesium, expressed 
as percentage of the total, was found in microsomes, followed by mitochondria and 
nucleus [24,25]. 
Table 1. Intracellular compartmentalisation of magnesium. 
nuclei 
mitochondria 
microsomes 
supcrnatant(microsol) 
%of 
total 
[25] 
16.3 
23.2 
45.2 
14.1 
Mg 
%of 
total Mg 
[26] 
13.4 
21.8 
48.0 
12.8 
In the different cell organelles magnesium is further compartmentalized; in 
mitochondria magnesium is localized for 4% at the outer membrane, 50% in the 
intermembranous space, 5% in the inner membrane and 41% is localized in the 
matrix [26]. In the cytosol 90% of magnesium is bound to ATP and other magnesium 
binding ligands, representing a intracellular magnesium buffer. 
Intracellular free magnesium 
Of the total intracellular magnesium less than 10% is present in the free ionized form, 
which is considered to be the metabolic active magnesium. Different techniques were 
used; metallochromic indicators, 31P NMR, nullpoint titration and ion-selective 
electrodes [27]. A wide range of [Mg2" ]^, is reported, depending on technique and 
investigator, but most probable estimates are in the range of 1 mmol per litre cell 
water. This is near the K,,, of many enzymes [28]. As the [Mg2"1"], is hold constant by 
very efficient cellular mechanisms, it is not likely that magnesium has a trigger 
function but must be regarded more a static than a dynamic regulator. 
MAGNESIUM TRANSPORT IN THE RED BLOOD CELL 
Erythrocytes lack intracellular compartments and therefore can more easily be used 
for magnesium transport studies. Of the total erythrocyte magnesium content only 
about 10% is present in the free ionized form with a concentration of 0.25 - 0.40 
mmol/1 cell water [29,30]. With a plasma ionized magnesium concentration of about 
0.5 mmol/1 and a membrane potential of 9 mV inside (negative), the predicted 
intracellular magnesium concentration should be »1 mM at electrochemical 
equilibrium [31]. In order to maintain the considerably lower measured values, red 
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cells must be impermeable to magnesium or must actively transport magnesium out of 
the cell. 
Magnesium influx 
Experiments using ^Mg showed very slow uptake of magnesium into human 
erythrocytes [32]. After 5 hours incubation with ^Mg added to the plasma only 
approximately 5% of the relative activity was detected in the erythrocytes. Ginsburg et 
al. could not detect any uptake of ^Mg by human red blood cells after 12 and 24 
hours [33]. Later, Watson and co-workers found an uptake of ^Mg into erythrocytes 
of 0.14 mmol/day, corresponding with approximately 60 /xmol/1 erythrocytes per day 
[34] while total magnesium content ranges from 1.69 - 2.99 mmol/1 erythrocytes [19]. 
Due to the inwardly directed electrochemical gradient for magnesium, the influx into 
erythrocytes is considered to be passive. 
Magnesium efflux 
In a recent review Flatman [31] states that erythrocyte magnesium efflux is active and 
does not occur through the sodium pump, calcium pump, Na-K-Cl cotransporter, K-Cl 
cotransporter, or anion exchange system. Human red blood cells have a specialized 
sodium dependent magnesium transporter. However, Günther and Vormann [35] 
showed that only 10% of the maximal net magnesium efflux from human erythrocytes 
is dependent on extracellular sodium and that 90% depends on net chloride efflux for 
charge compensation. 
MAGNESIUM HOMEOSTASIS 
Intestinal resorption 
The recommended daily intake of magnesium is 4-5 mg/kg of which 30-40% is 
absorbed in the intestinal tract (Fig. 2) [36]. After oral loading with ^Mg the major 
part of absorption occurred during the first 6 hours, pointing to absorption in the 
small intestine [37]. In their recent review Hardwick et al. [38] concluded that 
magnesium is resorbed predominantly in the distal small intestine. Passive paracellular 
diffusion through the tight junctions, driven by the electrochemical gradient across the 
epithelium, accounts for the majority of magnesium absorbed [38]. Besides passive 
diffusion, solvent drag mechanisms occur, whereas active transport is of minor 
importance in the intestinal magnesium resorption. 
The movement of magnesium across the basolateral membrane into the extracellular 
space is an active step. 
Factors modifying the absorption of magnesium include dietary intake, dietary calcium 
(conflicting results), vitamin D and parathormone. Both vitamin D and parathormone 
augment intestinal magnesium absorption [39]. In suckling, weanling and adult rats a 
developmental character of intestinal magnesium transport was noticed by Meneely et 
al. [40]. Younger rats had higher intestinal absorption rates than older ones. In 
children absorption studies after oral ^Mg gift and combined measurement of total 
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body retention and excretion of the isotope in urine and faeces revealed 24 - 32% 
intestinal absorption [41]. However absorption rates of 55 - 75% were also noticed 
[42]. Recently Schuette et al. [43] used ^Mg, a stable isotope, to investigate the 
intestinal magnesium resorption in three full term infants. When 20 mg of ^Mg was 
given over a 24 hour period a fractional resorption of 64.0% ± 3.9 was noticed [43]. 
This is nearly the doubled absorption rate reported by Lombeck et al. [41] but in the 
normal range of absorption found by Str0mme et al. [42] using ^Mg. 
INTAKE 
4 rag/kg.24hr. 
INTESTINAL TRACT 
4-5 mg/kg.24hc. 
FAECES 
2.5 mg/kg.24hr. 
INTESTINAL SECRETIONS 
0.5 mg/kg.24hr. 
INTESTINAL ABSORPTION 
2 mg/kg.24hr. 
BONE 60% 
OTHER TISSUES 4 0% 
incl. bloodcells 
EXTRACELLULAR SPACE 1% 
EXCRETION!urine) 
1.5 mg/kg.24hr. 
Figure 2. Body magnesium stores. 
Interactions between calcium and magnesium metabolism 
The relation between parathormone and magnesium levels are not straightforward. 
Acute lowering of serum magnesium seems to stimulate parathormone release, 
whereas chronic magnesium depletion is associated with lowered parathormone 
secretion [44]. Severe magnesium depletion can be attended with hypocalcemia. The 
combination of decreased parathormone release and bone resistance to parathormone 
might explain this association. In vivo and in vitro studies demonstrated inhibited PTH 
release during high magnesium concentrations [45,46]. 
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Interactions between potassium and magnesium metabolism 
Total body potassium in humans and animals is often reduced in magnesium 
deficiency [47]. During continuing magnesium depletion in humans, the accompanying 
intracellular potassium depletion cannot be restored with only extra supply of 
potassium, until magnesium is also replaced [48]. A decreasing intracellular 
magnesium content is associated with potassium efflux from the cell. In primary 
potassium depletion, intracellular magnesium can also be reduced. These 
interrelationships are not yet adequately explained. 
RENAL HANDLING OF MAGNESIUM 
Introduction 
Ultrafiltrable magnesium as determined with the Amicon filter technique in plasma 
amounts to 0.60 ± 0.07 mmol/1 (mean ± 1 sd). With a normal glomerular filtration 
rate of 120 ml/min, the filtered load can be calculated to be 104 mmol or 2500 
mg/day. As the normal excretion in adults is 3 - 6 mmol/24 hours, this means that the 
urinary output represents about 5% of the filtered load of magnesium As magnesium 
absorption is essentially unidirectional 95% will be reabsorbed by the renal tubules. 
Superfictol Prosimol Loop OtHol Unn« 
Figure 3 Summary of the fraction of filtered load of magnesium and sodium remaining along the 
proximal and distal tubules and final urine of normal dogs Fractions of filtered load are expressed as 
(TF/UF Na or Mg) / (TF/P inulin) χ 100 From [49] with permission. 
Renal magnesium reabsorption is clearly different from the reabsorption of sodium 
and calcium as is shown in figure 3. This figure illustrates the proximal and distal 
tubule-reabsorption and also the final urme of normal dogs [49]. The same scheme 
applies to all species investigated [50]. In contrast with a fractional reabsorption for 
sodium and calcium of 50-60% in the proximal tubules, some 20-30% of the filtered 
magnesium is reabsorbed in this part of the nephron. The major portion of 
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magnesium (» 65%) is reabsorbed within the loop of Henle mainly in the thick 
ascending limb. About 10% of the filtered magnesium reaches the distal nephron, 
where only a small fraction is reabsorbed. 
Tubular reabsorption 
As excellent reviews [49-53] about this aspects are available we will only briefly review 
the tubular reabsorption and stress the points needed to understand the content of 
this thesis. 
Proximal convoluted tubule 
Luminal magnesium concentration rises along the length of the proximal tubule to be 
1.7 with respect to ultrafiltrated magnesium at a point where 50 to 55% of sodium 
and water had been reabsorbed. The proximal tubule epithelium possesses a low 
permeability for magnesium relative to sodium or calcium. 
The segmental reabsorption of Mg, Ca and Na in normal animals is shown in table 2 
The reabsorption rate is dependent on the luminal magnesium concentration as was 
shown using m vivo microperfusion technique. 
Table 2. Segmental reabsorption of Mg, Ca and Na in normal animals. 
Collection site 
Glomerulus 
Proximal convoluted 
tubule 
Descending limb of 
Henle 
Early distal 
tubule 
Late distal 
tubule 
Urine 
TF/Pmuhn 
10 
25 
45 
5 0 
100 
TF/PNa 
10 
10 
25 
0 4 
025 
TF/UFo, 
10 
12 
2 5 
0 4 
025 
TF/UFMi 
10 
2 0 
4 0 
0 6 
0 8 
Fraction of filtered load ι 
at collection site 
н2о 
100 
40 
22 
20 
10 
1 
Na + 
100 
40 
55 
8 
2 
05 
Ca2 + 
100 
48 
55 
8 
2 
05 
remaining 
Mg 2 + 
100 
80 
90 
12 
8 
5 
Data represent mean approximations at the end of the respective accessible nephron segments 
TF/P and TF/UF are tubular fluid/plasma or ultrafillrablc plasma concentration ratios [53] 
Proximal straight tubule and thin descending limb of Henle's loop 
In-vitro perfusion studies of isolated straight proximal segments of the rabbit showed 
the same characteristics for magnesium transport as in the proximal convoluted 
tubule. In the descending limb of Henle magnesium is added at the same time as 
water is abstracted. 
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Thick ascending limb of Henle's loop 
This is the major segment of the nephron reabsorbing filtered magnesium. There is a 
dependence of magnesium transport rate with the load of Mg delivered to the loop of 
Henle, whether delivery is altered by increasing luminal Mg concentration or 
increasing flow rate. The increasing flow rate may cause Mg absorption to increase 
because the Mg concentration in tubular fluid increases along the length of the thick 
ascending limb. Elevation of luminal Mg 10-fold above normal has no effect on net 
sodium or calcium transport within the thick ascending limb. In contrast elevation of 
the plasma magnesium concentration at the basolateral membrane markedly 
depresses magnesium reabsorption. Net sodium absorption is not reduced by 
peritubular Mg but net calcium transport was significantly reduced (Fig. 4). 
Hypercalcemia inhibits both magnesium and calcium reabsorption in the loop of 
Henle by an unknown mechanism. 
The thick ascending limb comprises cortical (CTAL) and medullary (MTAL) portions. 
Both types of cells possess an electroneutral Na+-2C1"-K+ cotransporter at the apical 
side and an Na+-K+-ATPase at the basolateral membrane (Fig. 5). 
The K+ entering the cell is recycled through the apical K+-channel. CI' is extruded 
from the cell via chloride conductance. The presence of a large potassium conduction 
across the luminal membrane and the СГ exit across the basolateral membrane 
provides the basis for the lumen-positive transepithelial potential. 
Although the CTAL and MTAL have the same morphological organization, the cells 
of the cortical portion are narrower and have a simpler ultrastructural organization. 
There is also a clear functional heterogeneity. In the rat the adenylcyclase system of 
the CTAL and MTAL are both sensitive to ADH, glucagon and calcitonin. Only 
CTAL is sensitive to PTH. 
In the mouse CTAL was sensitive to all tested hormones, ADH, glucagon, calcitonin 
and PTH whereas in MTAL the cyclase system was only stimulated by ADH and 
glucagon. Most important are the results of the effect of ADH on transepithelial СГ, 
K+, Ca2 + and Mg2+ net transport in TAL performed in vitro. 
ADH stimulated Ca and Mg reabsorption in the cortical part and Na+ and CI" 
reabsorption in the medullary part of this nephron segment. In the normal situation 
the Ca and Mg resorption was almost limited to CTAL. 
The problems of active and or passive transport in TAL is not completely solved. 
Mg2"1" may pass through the paracellular pathway driven in a passive fashion by the 
transepithelial potential difference and active sodium transport. Alternatively Mg 
absorption may be active as well as transcellular in nature. 
Glucagon and ADH increases Mg2+ transport with no alteration in Potential 
Difference, transepithelial resistance or NaCl absorption in CTAL of the mouse 
suggesting an active component for magnesium. 
As is evident from Fig. 5 paracellular and transcellular magnesium absorption is 
related tot active Na+ transport in TAL. An altered transepithelial voltage will 
influence an active and passive transport of magnesium. The transport of NaCl is 
normally greater in MTAL than in CTAL, but the CTAL maintains greater 
transepithelial concentration differences. 
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Distal convoluted tubule and collecting duct 
Normally a small portion of magnesium is reabsorbed in the distal convoluted tubule. 
The reabsorption is close to its capacity whereas the calcium and sodium transport is 
normally unsaturated. 
The collecting duct plays a very limited role in renal magnesiumtransport. 
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Figure 4. Effect of luminal magnesium versus peritubular magnesium concentration on net Mg, Ca and 
Na reabsorption in the loop of Henle. From [53] with permission. 
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Figure 5. Schematic model of magnesium reabsorption m the thick ascending limb of Henlc's loop 
Conductive pathways are denoted by dashed arrows and carrier-mediated Iransport by solid arrows 
Active transport processes are indicated by - symbol. From [S3] with permission 
DISTURBED MAGNESIUM HOMEOSTASIS 
Many causes and factors of disturbed magnesium homeostasis leading to magnesium 
deficiency or hypomagnesemia are known. 
Five main-groups can be formed (table 3) [54]; reduced intake, impaired intestinal 
resorption, excessive urinary losses, excessive losses of body fluids and intracellular 
shifts. In acute pancreatitis the hypomagnesemia might be caused by the precipitation 
of insoluble magnesium soaps in the omentum [55]. 
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Although low serum magnesium concentrations usually imply intracellular magnesium 
depletion, intracellular magnesium depletion is reported despite normal serum 
magnesium levels. Conversely, low serum magnesium concentrations have been 
reported m patients with normal cellular magnesium content and no clinical signs of 
deficiency [56]. For many years there was uncertainty about the existence of a 
Table 3. Mechanisms and causes of hypomagnesemia 
I 
a 
b 
с 
d 
II 
a 
b 
с 
III 
a 
b 
с 
d 
Reduced intake 
prolonged intravenous therapy 
without sufficient magnesium 
starvation 
protein calorie malnutrition 
alcoholism 
Impaired intestinal resorption 
chronic diarrhoea 
malabsorption syndromes 
primary hypomagnesemia 
Excessive urinary losses 
polyuria 
hypercalcemia 
drug-induced by furosemide, 
thia7ides, gentamycin, 
amphoten-cin B, usplatin, 
cyclosporin, ifosfamide 
Renal diseases 
-renal tubular acidosis 
-chronic glomerulo-pyelonephntis 
d 
e 
f 
Ê 
h 
-specific tubular disorders 
diabetes 
hypcraldosteronism 
hyperthyroidism 
inappropriate antidiuretic hormone 
alcoholism 
potassium depletion 
IV Excessive losses of body fluids 
a 
b 
с 
d 
V 
a 
b 
с 
d 
e 
prolonged nasogastric suction 
intestinal fistula 
excessive lactation 
exchange transfusion with blood anti-
coagulatcd with citrate 
Intracellular shifts 
postparathyroidectomy 
rcfeeding after starvation 
insulin treatment 
correction of acidosis 
acute pancreatitis 
From D Juan [54] 
pure magnesium deficiency state in man because hypomagnesemia is often 
accompanied by other electrolyte disturbances. The experimental magnesium 
deficiency study in man performed by Shils [47] showed that urinary magnesium 
excretion drops very quick and is below 1 mmol/day after 3 days of depletion. Serum 
magnesium lowers gradually and erythrocyte magnesium content follows the trend in 
serum with some delay. One or more signs of magnesium deficiency developed in 24 
to 102 days in six of seven depleted persons. 
Detection of magnesium deficiency 
The incidence of magnesium deficiency is still subject of debate. In severe depletion a 
lowered serum magnesium level combined with a nearly absence of magnesium in the 
urine is found, but several authors report a normomagnesemic magnesium deficiency. 
In this situation urinary magnesium excretion is in the lower range 
of normal, but not as low as m severely magnesium depleted patients. Increased 
magnesium retention was noticed during normal serum magnesium levels in alcoholics, 
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a situation with a known relation to magnesium depletion compared to controls [56]. 
Erythrocyte and mononuclear magnesium content are reported to be helpful in 
diagnosing magnesium deficiency but both have wide normal ranges and are not a 
standard tool at this moment. 
Different types of magnesium loading tests are developed; urinary magnesium 
excretion before and after an intravenous or intramuscular load with magnesium in 
different dosages is measured and the magnesium retention calculated. Although 
Table 4. Symptoms of magnesium depletion. 
apathy hallucinations 
anorexia, nausea and vomiting tremulousness 
muscular weakness hyperrcflexia 
spasmophillia positive Chvostck sign 
myophatic potentials on the eleciromyogram posititive Trousseau sign 
low voltage T-wave and PQRS-complex, gross muscular tremor 
short PR-interval on the electro- chonform movements 
cardiogram ataxia 
confusion tetany 
depression vertigo 
agitation delirium 
epileptiform convulsions 
unne collection is the cornerstone of these tests, the pre-load urine period, mostly 
eight hours, is rather short for adequate judgement of basic magnesium excretion. In 
prematures and newborns the low renal magnesium clearance due to the low 
glomerular filtration rate may lead to falsely high magnesium retention because of the 
relatively short period of post-load urine collection (32 hours) in the magnesium load 
test, designed by Byrne and Cadell [57]. 
ASPECTS OF DISTURBED MAGNESIUM HOMEOSTASIS IN CHILDHOOD 
Decreased intake 
Although causes and mechanisms of abnormalities in magnesium homeostasis are 
generally the same in adults and children, some differences especially in neonates and 
infants are noticed. 
In neonates the magnesium content ranges from 7-10 mmol/kg body weight [58], 
serum levels are significantly lower on the first day [59] and increase considerably 
during the first three days after birth [60]. This rise of the serum magnesium level is 
accompanied by low urinary magnesium excretion of 0.34, 0.13 and 0.13 mg/kg body 
weight on the first, second and third day respectively [61]. 
Under standardised conditions with a magnesium intake of 10.5 ± 3.7 mg/kg.day m 
normal infants and children with ages from one month to 14 years, an urinary 
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excretion of 2.8 ± 1.1 mg/kg.day with a range from 0.9 - 5.2 was reported by Paunier 
et al. [62]. In a larger study, where home made food was ingested, urinary magnesium 
excretion was in the same range (2.03 ± 0.77 mg/kg.day) and a circadian rhythm 
noticed [63]. Significant higher magnesium (and calcium) excretion was found in 
overnight urine. 
Common causes of neonatal hypomagnesemia are intrauterine growth retardation, 
where hypomagnesemia is considered to be a part of the syndrome with decreased 
placental transfer of magnesium or altered fetal magnesium metabolism [64], 
exchange transfusion with blood anti-coagulated with citrate, malabsorption syndromes 
such as biliaiy atresia, mostly after intestinal surgery, and maternal hypomagnesemia 
[61]. Decreased maternal magnesium intake, overuse of stoolsofteners and diabetes 
are also frequently noted causes [61]. 
Very rare is primary hypomagnesemia with secondary hypocalcemia characterized by 
recurrent tetany and convulsions [65]. Restoration of a normal serum magnesium level 
results in immediate cessation of the convulsions and a gradually normalisation of the 
serum calcium level. Primary impairment of the intestinal absorption of magnesium is 
the underlying defect. First symptoms are noticed from 9 days to four month after 
birth. Male to female ratio is 6 to 1 and the most likely mode of inheritance is 
autosomal recessive [66]. Livelong supplementation with high dose magnesium is 
necessary and prognosis appears good when the illness is diagnosed and treated 
promptly. 
Increased magnesium loss 
Increased magnesium losses leading to hypomagnesemia are reported in diuretic 
therapy and renal disorders. In table 3 the renal diseases resulting in hypomagnesemia 
are listed. The specific syndromes with renal magnesium loss will be discussed in more 
detail. 
The diagnosis renal magnesium loss is established by the presence of hypomagnesemia 
with an inappropriately high 24 hour urinary magnesium excretion. Other causes of 
high urinary magnesium excretion must be excluded for example diabetes mellitus, the 
use of osmotic agents and diuretics [67]. Many of these renal magnesium loosing 
syndromes are hereditary disorders, but also isolated patients are reported [68]. 
Hypomagnesemia is often not the only abnormality noticed in these patients; 
combinations with hypokalemia, hypocalcemia, impaired concentration capacity of the 
kidney and/or nefrocalcinosis are frequently reported. 
Rodriguez-Soriano [69] distinguishes three different types of hereditary renal 
magnesium loss: Isolated familial hypomagnesemia, familial hypokalemia-
hypomagnesemia and familial hypomagnesemia-hypercalciuria. 
Isolated familial hypomagnesemia was first reported in 1966 by Freeman and Pearson 
[70] in a woman and one of her five children. The absence of hypokalemia or 
nephrocalcinosis separates this entity from the two other entities. Two new families 
are described in this thesis. 
Patients with Familial hypokalemia-hypomagnesemia, also known as Gitelman's 
syndrome [71] are often asymptomatic but transient episodes of muscular weakness 
and tetany are reported. There is no growth retardation, or polyuria. Urinary calcium 
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excretion is low (0.3 ± 0 . 1 mg/kg.day) and discrimination from Bartter's syndrome is 
sometimes difficult. This point will be treated in chapter 9. 
Of the familial hypomagnesemia-hypercalciuria syndrome until now 18 patients are 
reported [69]; the absence of growth retardation, hypokalemia, and a tendency to 
metabolic acidosis distinguishes them from Bartter's syndrome patients. 
Hypomagnesemia is always accompanied by hyperuricemia and nephrocalcinosis. 
Ocular abnormalities such as myopia and horizontal nystagmus are often present. 
Defects in concentrating capacity and distal urinary acidification are probably 
secondary to nephrocalcinosis. 
Hypermagnesemia 
Cardiac conduction is affected at serum concentrations of 2.5 to 5.0 mmol/1, resulting 
in increases in the PR interval and QRS duration. Hypotension may occur. Deep 
tendon reflexes are lost when serum magnesium concentration approaches 5 mmol/1 
and respiratory arrest occurs near 7.5 mmol/1. Extremely high serum concentrations 
(>12.5 mmol/1) cause cardiac arrest [72]. In adults, hypermagnesemia is mostly seen in 
renal insufficiency when glomerular filtration rate falls below 30 ml/min. Suppletion 
with magnesium to prevent hyperphosfatemia can have an additional effect in renal 
insufficiency. 
In neonates hypermagnesemia mostly is induced by maternal hypermagnesemia due 
magnesium sulphate infusions in pre-eclampsia [60]. The low glomerular filtration rate 
present in newborns causes a slow return to normal serum magnesium values. 
THE AIM OF THIS THESIS 
The origin of this investigation was based, as often in clinical medicine, on a clinical 
observation. 
A family with isolated magnesium wasting was studied. It appeared to be an 
autosomal dominant form of renal magnesium loss. Although this disorder was already 
mentioned in the literature, it was not established as an entity. Another family with 
isolated renal magnesium loss and autosomal recessive form of inheritance was also 
observed. It was striking that although the level of serum magnesium was distinctly 
decreased, they had almost no clinical symptoms. 
What was the relation between a lowered serum magnesium and the magnesium body 
stores? 
An experimental study was planned in dogs. They received a magnesium deficient diet 
during several weeks. Neither the leucocyte content neither the bone content of 
magnesium but the content of erythrocyte magnesium appeared to be a good 
reflection of body magnesium stations (Chapter 6). The rate of decrease of 
erythrocyte magnesium compared with serum magnesium was studied in chapter 6 
and 7. As the "metabolic" active form of intracellular magnesium is ionized 
magnesium, ionized magnesium was measured by the NMR technique, in erythrocytes 
of the experimental dogs and in patients with disturbances in tubular magnesium 
reabsorption (chapter 7 and 8). To validate the NMR technique, the results of the 
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NMR technique in erythrocytes was compared with the results of the zeropomt 
titration method (chapter 8). 
The developed techniques were ultimately applied in patients with tubular disorders 
with possible magnesium depletion and described in chapter 8 and chapter 9. 
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SUMMARY 
Renal magnesium wasting in two families with autosomal dominant inheritance. 
Hypomagnesemia due to isolated renal magnesium loss was demonstrated in two 
unrelated families with autosomal dominant mode of inheritance. Magnesium 
infusions performed in two patients showed not only a reduced renal magnesium 
threshold but also a lowered renal tubular maximum for magnesium. All members of 
both families who presented with hypomagnesemia had also a lowered excretion of 
calcium in the urine, presumably as a consequence of increased reabsorption in 
Henle's loop. 
INTRODUCTION 
Magnesium depletion due to congenital impairment in tubular reabsorption of 
magnesium is uncommon. Generally it is part of a more extensive tubular disturbance 
[1]. Isolated magnesium loss by the kidney appears to be extremely rare. The aim of 
this study is to report renal magnesium wasting in two unrelated families with 
autosomal dominant mode of inheritance. All family members who presented with 
hypomagnesemia, had also a lowered urinary excretion of calcium presumably as a 
consequence of hypomagnesemia. 
METHODS 
Case histories 
M.C., the second child of an apparently normal family, was admitted at the age of 13 
years because of generalized convulsions. After symptomatic treatment she 
complained of hallucinations and anxiety during one week. She had no previous 
0-Γ0 
-o • -Ώ 
- • D O 
F a m С 
— Personally examined 
Figure 1. Pedigree of family C. Roman numerals for the different generations. Every generation 
member is designated by an Arabic numeral from the left to the right. Autosomal dominant mode of 
inheritance is presented. Arrow (.·) indicates patient M.C.; (-) indicates patient personally examined. 
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medical problems with the exception of some circumoral numbness. Extensive 
neurologic investigations revealed no abnormality (CAT-scan, cerebral angiography). 
A low serum magnesium (0.40 mmol/liter) was measured (normal 0.75 to 1.25 
mmol/liter). Laboratory data revealed a normal serum sodium 138 to 141 mEq/liter, a 
normal serum potassium 3.8 to 4.2 mEq/liter, a normal serum chloride 101 to 105 
mEq/liter, normal serum bicarbonate 26.2 mEq/liter, normal blood pH 7.36, normal 
serum calcium 2.45 mmol/liter, and normal ionized calcium 1.23 mmol/liter. Plasma 
renin activity and plasma aldosterone were in the normal range [2]. Parathormone 
level was 7.6 pmol/liter (normal <10). Calcitonin concentration was 62 pg/ml (normal 
47 ± 24 pg/ml). Serum magnesium measurements performed in other members of the 
family indicated an autosomal dominant mode of inheritance (Fig. 1). The renal 
function and magnesium metabolism was more extensively studied in this girl. 
JZf-r-Ö 
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Figure 2. Pedigree of family В Roman numerals for the different generations while every gcnrcation 
member is designated by an Arabic numeral from the left to the right Autosomal dominant mode of 
inhentence is shown. Arrow (>•) indicates patient J В,(-) indicates patients who were personally 
examined, (0) indícales pregnancy. 
J.B., the second child out of four children had an uneventful neonatal period after 
normal pregnancy. At the age of seven months he presented with generalized 
convulsions. Since that time he was treated by several anti-epileptic drugs. Severe 
psychomotoric retardation became evident. At the age of 15 years serum magnesium 
was measured for the first time and amounted to 0.39 mmol/liter. Routine laboratory 
data showed a normal serum sodium 137 to 145 mEq/liter, a normal serum potassium 
3.9 to 4.2 mmol/liter, a normal serum chloride 104 mmol/liter, a normal serum 
bicarbonate 24.2 mmol/liter, normal blood pH 7.40, normal serum calcium 2.45 
mmol/liter, and normal ionized calcium 1.26 mmol/liter. Plasma renin activity, plasma 
aldosterone, plasma parathormone level (6.3 pmol/liter) and plasma calcitonin 
concentration (47 pg/ml) were in the normal range. Studies of serum magnesium 
levels in other members of the family demonstrated an autosomal dominant mode of 
inheritance (Fig. 2). Also in this boy the renal function and magnesium metabolism 
was more completely studied. His severe mental retardation prohibited some 
experimental studies. 
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Methods 
The 62 microglobulin clearance and D.D.A.V.P. test were performed according to Van 
Oort, Monnens and van Munster [3] and Monnens et al [4]. The normal values for the 
phosphate reabsorption and tubular maximum for phosphate are from Kruse, Kuacht 
and Göpfert [5]. The acid loading test according to Berg, Aperia and Broberger [6] 
was done only in the first patient. Human intact parathormone was measured by 
radioimmunoassay (Immuno Nuclear Corporation, Stillwater, Oklahoma, USA). 
Human calcitonin was also measured by radioimmunoassay (Immuno Nuclear 
Corporation). 
The renal magensium threshold and Tm Mg werd determined according to Rude, 
Bethune and Singer [7]. The glomerular filtration rate was measured by the use of 
inulin. The ultrafíltrable serum magnesium fraction was obtained with the use of 
Amicon Centrifugo ultrafiltration cones (Amicon, Lexington, Massachusetts, USA). 
Serum and urinary magnesium concentrations were determined by atomic absorption 
spectrophotometry. 
In three healthy young adults we found for the magnesium threshold 1.49; 1.25; 1.46 
ultrafiltrable-serum-Mg mg/100 ml GFR 1.73 m2. These values are within the 95% 
confidence limilts of Rude, Cohen and Singer [8]. 
Table 1. Renal function in both patients 
fcndogenous clearance ot 
creatinine 
inulin clearance 
ml/min/1.73 m2 S.A. 
&2 microglobulin clearance/ 
endogenous clearance of 
creatinine 
Phosphate reabsorption 
Tm phosphate 
nmol/min/100 ml GFR 
Proteinuria 
Glucosuria 
Abnormal aminoaciduria 
D.D.A.V.P.-test 
mOsm/kg 
Acid loading test 
according to Berg et al 
Calciuria 
M.C. 
136-140 
109 
0.5% 
88-92% 
0.98 
absent 
absent 
absent 
1056 
normal 
0.13-0.34 mmol/ 
24 hr 
J.B. 
122-125 
91 
-
87-93% 
1.00 
absent 
absent 
absent 
1129 
-
0.57-0.88 mmol/ 
24 hr 
Intestinal magnesium absorption studies were made with ^Mg [9]. After fasting 
overnight 900 kBq (kiloBequerel),(24 дСі)28 Mg, dissolved in 0.01 mol HCl, was given 
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orally to the patient. During seven days, the radioactivity present in the urine and 
faeces was measured and expressed as percentage of the oral dose. Moreover, in 
patient MC the total body radioactivity was measured with a shadow-shield Whole 
Bodycounter. After correction for physical decay and for the background radiation, 
measured just before the administration of the dose, the retention could be 
determined. If measurements with the Whole Bodycounter were not performed (JB), 
the absorbed fraction was calculated as the difference between the administered dose 
and the amount of radioactivity, found in the feces. 
A renal biopsy was taken percutaneously in the second patient and prepared for light 
microscopy, immunofluorescence and electronmicroscopy with routine techniques. 
RESULTS 
The renal function of both patients is presented in Table 1. The only abnormality 
observed with the exception of the magnesium metabolism was a lowered excretion of 
calcium in the urine. Normally the calcium excretion in children varies between 1.1 
and 7.4 mg/kg/24 hours [10]. 
Almost all family members with a lowered serum magnesium also showed a lowered 
calcium excretion in the urine. The only person with a low calcium excretion and a 
normal serum magnesium was an 82 year-old lady (Fig. 3). 
Urinary Ca excretion mg/kg.2Ahr 
o 4 0 
3 0 - , 
2 0 
1 0 
• fam В 
o lam С 
о о 
• о 
• · 
•о · 
• »с» · 
— ι 1 г 
0 5 10 
Serum Mg m m o l e / l i t e r 
Figure 3. Urinary calcium excretion related to Mg serum level in both families. Symbols are: (·) family 
B; (o) family С 
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Table 2. Serum magnesium and urinary magnesium excretion in 
both patients 
M.C. J.B. 
Serum magnesium 0.38-0.56 mmol/liter 0.39-0.55 mmolyliter 
Urinary excretion 
of magnesium 8.3 mmol/24 hr 7-9.5 mmol/24 hr 
All family members had a normal serum calcium concentration. The values of the 
serum magnesium and magnesium excretion in the urine of both families are shown in 
Table 3. Wilcoxon two-sample test showed a highly significant difference (P<0.001) in 
calcium excretion between the normo- and hypomagnesemic persons. 
Table 3. Magnesium and calcium levels in serum and urinary excretion of magnesium 
and calcium in members of both families 
Urinary excretion of 
Serum Mg Serum Ca Mg Ca 
s a Age mmol/1 mmol/1 mmol/24hr mmol/Whr 
Family С 
IM 
II-3 
II-5 
III-1 
III-3 
Family В 
II-l 
II-3 
II-5 
II-7 
II-9 
11-11 
11-15 
11-16 
III-l 
III-9 
III-10 
III-11 
Ш-13 
III-15 
III-16 
III-18 
III-21 
M 
F 
F 
M 
F 
F 
F 
F 
F 
F 
F 
M 
M 
F 
M 
M 
F 
M 
F 
M 
F 
M 
48 
44 
37 
20 
13 
53 
51 
50 
48 
46 
45 
42 
38 
29 
23 
22 
21 
23 
20 
13 
17 
9 
0.52 
0.65 
0.53 
0.46 
0.57 
0.47 
0.32 
0.35 
0.52 
0.46 
0.46 
0.38 
0.34 
0.32 
0.42 
0.50 
0.50 
0.44 
0.58 
0.60 
0.54 
0.52 
2.44 
2.46 
2.40 
2.42 
2.48 
2.29 
2.32 
2.38 
2.36 
2.32 
2.34 
2.46 
2.29 
2.24 
2.48 
2.52 
2.40 
2.56 
2.46 
2.37 
2.28 
2.46 
6.9 
4.1 
3.1 
7.8 
3.5 
8.3 
5.5 
4.9 
5.5 
4.1 
6.6 
6.2 
5.1 
3.9 
2.5 
6.9 
5.6 
3.6 
4.2 
3.0 
0.2 
0.5 
1.3 
1.1 
0.5 
0.4 
1.1 
0.9 
0.3 
0.6 
0.2 
1.3 
0.6 
0.4 
0.2 
0.3 
0.2 
0.4 
1.7 
0.2 
36 
For the ^Mg resorption studies, we used exactly the procedure as proposed by 
Becker, Lombeck and Bremer [9]. In normal adults the total body retention after 72 
hours is 20 to 34%, the resorption is 24 to 32%. 
Figure 4 shows the results of the oral 28Mg resorption test in M.C. The total body 
retention was higher than normal as well as the resorption by the gut. J.B. excreted 
51.8% of the amount ingested in his feces by 72 hours. Urinary excretion amounted to 
13.6% of the administered dose. The calculated retention was 34.6, the calculated 
resorption of 48.2% was increased. 
Oral 2 e M g resorption test 
faecal 
excretion 
ι ι 1 1 1 1 1 
1 2 3 A 5 6 7 
Time days 
Figure 4. Oral ^Mg resorption test in patient M.C shows a high resorption rate. 
The results of the magnesium infusions are shown in Figure 5. Not only the renal 
magnesium threshold but also the Tm Mg was lowered in both patients. Triamterene 
\L
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administration was not able to reduce the urinary magnesium excretion in both 
patients [11]. 
Renal biopsy findings in J.B. 
Light microscopy and immunofluorexcence study (IgG, IgM, IgA, C, , C3, fibrin, 
albumin) revealed no abnormalities. Under electromicroscopy the glomeruli appeared 
normal. The thickness and structure of the tubular basement membrane were normal. 
Family studies 
In the indicated members (see Table 3, Figs. 1 and 2) of both families serum 
magnesium and urinary excretion of magnesium and calcium were measured. The 
presence of hypomagnesemia in successive generations and the male to male 
transmission proves the existence of an autosomal dominant mode of inheritance. 
Urinary 
Mg2 +excretion mg/100ml GFR. I 73 m 2 
3 0 n 
2 0 -
1 0 -
3 0 АО 
uf M g 2 * mg/100 m I 
Figure 5. Ultrafiltrable serum magnesium concentrations are plotted against urinary magnesium 
excretion in patient M.C.(A) and J.B.(·) prior to and dunng magnesium infusions. Urinary excretion 
along the ordinate is expressed as mg/100ml glomerular riltrate/1.73 m2 surface area. The 
concentrations of ultrafiltrable magnesium are presented along the absissa. The broken line represents 
!he normal regression line according to Rude et al.[7]. 
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DISCUSSION 
Disorders causing magnesium deficiency commonly occur in the gastrointestinal tract 
or the kidney. A defect in the intestinal absorption of magnesium could be excluded in 
our patients. During magnesium deprivation urinary magnesium excretion can be 
found to be as low as 0.2 to 0.4 mmol/24 hours [12]. In our patients the urinary 
excretion of magnesium was in the normal range, although the serum magnesium 
concentration was distinctly lowered, pointing to a disturbance of tubular reabsorption 
of magnesium. The different causes of renal magnesium loss causing magnesium 
deficiency are reviewed by Rude and Singer [13]. Hypercalcemia, primary 
aldosteronism, the use of drugs such as cis-platinum, osmotic diuresis and a number of 
different renal diseases causing renal tubular damage could be eliminated as an 
explanation for renal magnesium loss in our patients. 
The absence of clinical symptoms related to Mg deficiency in our two families was 
striking. Muscular weakness and incoordination, ataxia, vertigo, coarse and irregular 
tremor were absent. Positive Chvostek's and Trousseau's signs could not be elicited. 
Frank tetany was never observed. Gastrointestinal symptoms were lacking. The 
electrocardiogram and electromyogram revealed no abnormalities. The adult patients 
in the second family (J.B.), however, developed symptoms of pseudogout. This can 
possibly be related to low values of magnesium and alkaline phosphatase activity in 
the synovial fluid [14]. The lack of these symptoms in our first family still requires an 
explanation. In both patients normal levels of intact parathormone were measured. 
This is reflected in the normal values for Tm phosphate. The influence of chronic 
hypomagnesemia on parathyroid hormone excretion is confusing. Both lowered and 
increased levels are reported in human beings [15]. 
Various micropuncture methods have characterized the tubular handling of 
magnesium [16]. In the proximal convoluted tubule 20 to 30% of the filtered 
magnesium. The distal convoluted tubule reclaims only 1 to 5% of filtered magnesium. 
The loop of Henle has a major role in the reabsorption of magnesium. 
The calcium-magnesium interaction located at the basolateral membrane of the loop 
of Henle allows greater levels of calcium reabsorption when the plasma magnesium 
concentration is depressed. This speculative model of magnesium transport by the 
thick ascending limb of Henle's loop is in agreement with the hypocalciuria detected 
in our patients. 
Hereditary isolated renal magnesium loss is, as far as we know, for the first time 
described in 1966 by Freeman and Pearson [17]. The hypomagnesemia due to urinary 
loss of magnesium was present in a mother and one of her five children. When serum 
magnesium varied between 0.45 and 0.50 mmol/liter the calcium excretion varied 
between 74 and 140 mg/24 hours or 1.6 to 3.1 mg/kg/24 hours. This calcium excretion 
is higher than measured in the members of our two families with hypomagnesemia. 
Milazzo et al [18] described also a mother with pseudo-gout and hypomagnesemia. 
Hypomagnesemia was also present in one of her two children, a 22-year-old son. The 
calcium excretion amounted to 26 mg/24 hours in the mother and to 52 mg/24 hours 
in her son, both low values. Information is not available about the hereditary 
character or the calciuria of the three patients with magnesium depletion secondary to 
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a renal magnesium leak described by Rude, Cohen and Singer [8]. In contrast to their 
patients, the renal-tubular maximum for magnesium was lowered in our two patients. 
This Tm process, however, is a composite of distinct transport properties of the 
proximal tubule and the loop of Henle as shown by Wong, Dirks and Quamme [19]. 
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SUMMARY 
A familial autosomal recessive form of isolated renal magnesium loss is presented. 
Two children in this family suffered from convulsions unrelated to hypomagnesemia. 
Magnesium infusion studies revealed a lowered threshold but a normal tubular 
maximum for magnesium. 
In contrast to two families with the autosomal dominant form of isolated renal 
magnesium wasting, the calcium excretion in the urine was normal. 
INTRODUCTION 
Magnesium depletion due to congenital impairment in tubular reabsorption is 
uncommon. Mostly it is part of a more extensive tubular disturbance (Evans et al. 
1981). Isolated magnesium loss by the kidney appears to be extremely rare. Recently 
we reported two unrelated families with renal magnesium loss with autosomal 
dominant inheritance (Geven et al. 1987). In this study we present two sisters with 
isolated magnesium wasting. The inheritance is of the autosomal recessive type. 
PATIENTS AND METHODS 
V.v.d. E (patient 1) is the fourth of four children. She was evaluated for moderate 
psychomotor retardation and convulsions at 4 years of age. Uneventfull birth took 
place after a normal pregnancy. The first generalised convulsion occurred at the age 
of three months. Neurologic investigation showed delayed speech and linguistic 
development. The electroencephalogram presented no epileptic activity, while a 
CT-scan showed a mild to moderate central and cortical atrophy of both hemispheres. 
Therapy with valproate was started. 
Serum magnesium was 0.56 mmol/1 (normal 0.75-1.20 mmol/1). Laboratory data 
revealed a normal serum sodium 138 to 143 meq/1, normal serum potassium 4.0 to 4.5 
meq/1, normal serum choride 105 meq/1, normal serum bicarbonate 26.0 mmol/1, 
normal blood pH 7.40, normal serum calcium 2.32 to 2.48 mmol/1 and a normal 
ionized calcium (1.30 mmol/1). Plasma renin activity and plasma aldosterone 
concentration were in the normal range. Parathormone level was 5.8 pmol/1 (normal 
<10). Calcitonin concentración was 11 pmol/ml (normal < 28 pmol/ml). The 
intravenous urogram showed no abnormalities. 
Table 1. Serum magnesium and urinary magnesium excretion in both patients. 
patient one patient two 
serum magnesium 0.53-0.66 mmol/l 0.56-0.62 mmol/1 
urinary excretion 
of magnesium 2.9-3.7 тто1У24 hr 3.9-6.6 mmol/24hr 
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The renal function and magnesium metabolism were more extensively investigated in 
this girl (tables 1 and 2). 
S.v.d. E. (patient 2), a sister of patient 1, and 4 years older than her, was born at term 
after prolonged bedrest of the mother during pregnancy because of cervix 
insufficiency. Delivery was normal. In the first year convulsions were observed during 
febrile infectious periods. Therapy was started with phénobarbital and afterwards 
valproate was given. She showed mild psychomotor retardation. Neurologic 
investigation revealed no abnormalities except brisk tendon reflexes. 
Electroencephalogram showed an epileptic pattern after photostimulation. The 
CT-scan of the brain was normal. Laboratory investigations presented a low serum 
magnesium of 0.53 mmol/1 (normal 0.75 to 1.20 mmol/1), normal serum sodium 140 to 
141 meq/1, normal serum potassium 4.0 to 4.2 meg/1, normal serum bicarbonate 26.0 
mmol/1, normal blood pH 7.37, normal serum calcium 2.50 mmol/1 and normal ionized 
calcium 1.30 mmol/1. Plasma parathormone level (7.0 pmol/1) and plasma calcitonin 
(16 pmol/ml) were in the normal range. 
Table 2. Renal function in both patients. 
endogeneous clearance of 
creatinine 
inulin clearance 
тІ/тіп/ІЛЗ m2 S.A. 
Bj microglobulin clearance/ 
endogeneous creatinine clearance 
phosphate reabsorplion 
Tm phosphate 
mmol/min/100ml GFR 
proteinuria 
glucosuria 
abnormal aminoaciduria 
D.D.A.V.P. test 
mOsmolAg 
calciuria mg/kg/24 hr 
patient one 
86-157 
110-114 
0.04% 
85-95% 
1.1 
absent 
absent 
absent 
1056 
2.1-3.4 
patient two 
107-136 
84 
-
85-87% 
1.2 
absent 
absent 
absent 
-
1.9-2.0 
The B2 microglobulin clearance and D.D.A.V.P. test were performed according to van 
Oort et al. (1980) and Monnens et al. (1981). The normal values for the phosphate 
reabsorption and tubular maximum for phosphate are from Kruse et al. (1982). 
Human intact parathormone was measured by radioimmunoassy (Immuno Nuclear 
Corporation, Stillwater, Oklahoma, USA). The magnesium threshold and Tm Mg 
were determined according to Rude et al. (1980). The glomerular filtration rate was 
measured by use of inulin. The ultrafiltrable magnesium fraction was obtained with 
the use of MPS-1 system (Amicon, Danver, Massachustts, USA). Serum and urine 
magnesium concentrations were determined by atomic absorption spectrophotometry. 
In three healthy young adults we found for the magnesium threshold: 1.49; 1.25; 1.46 
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ultrafiltrable Mg mg/lOOml and the TmMg to be: 1.55; 1.10; and 1.15 mgMg/lOOml 
GFR. 1.73m2. These values are within the 95% confidence limits of Rude et al. 
(1980). 
Intestinal magnesium absorption studies were performed with ^Mg^Becker et al. 
1979). After an overnight fast 481 kBq (кі1оВеяиеге1),(=13дСі) ^Mg, dissolved in 
0.01 mmol HCl, was given to the patient orally. For 6 days, the radioactivity present in 
feces and urine was measured and expressed as percentage of the oral dose. At the 
same time the total body radioactivity was measured with a shadow-shield Whole 
Bodycounter. After correction for physical decay and for the background radiation, 
measured just before the administration of the dose, the retention could be 
determined. 
RESULTS 
Table 1 summarises serum magnesium levels and urinary excretion in the two sisters. 
The renal function of both patient is presented in table 2. All function studies 
revealed normal values including the calcium excretion in the urine. In relation to the 
low serum magnesium, the magnesium excretion in the urine was clearly too high. 
Mg excretion mg/100ml GFR-1 73 m 2 , 
о Patient one / r 
• Patient two / / 
Τ ι 1 η 
10 2 0 3 0 ¿.0 
uf Mg mg/100ml 
Figure 1. Ultraflitrable serum magnesium concentrations are plotted against urinary magnesium 
excretion in Palient 1 (o) and patient two (·) prior to and during magnesium infusions. Urinary 
magnesium excretion along the ordinate is expressed as mg/100 ml glomerular fillrale/1.73 m2 surface 
area. The concentrations of ultrafiltrable magnesium are presented along the abcissa. The broken line 
represents the normal regression line according to Rude et al (1980). 
2.0 
1 0 -
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Figure 1 shows the results of the magnesium infusions. The renal magnesium 
threshold was lowered (0.91 and 1.08 mg uf-Mg/100 ml, respectively) in both patients, 
while the TmMg appeared to be normal.For the ^Mg resorption studies, we used 
exactly the procedure proposed by Becker et al (1979). In normal adults the total 
body retention after 72 hours is 20 to 34%, the resorption is 24 to 32% Figure 2 
presents the results of the oral ^Mg resorption test in Patient 1. The total body 
retention and resorption by the gut were higher than norma]. 
Oral 2 BMg resorption test (7.) 
100 
8 0 -
60 
40 
20 
1 
VdvE 110677 
sum total body retention 
•urinar y excretion 
· · 
total body retention 
urinary excretion 
• · 
л—" 
faecal excretion 
- ι 1 1 г 
4 5 6 7 
Time (days) 
Figure г Oral Mg resorption test in Patient 1 shows a high resorption rate. 
Family studies 
In the family members indicated (fig. 3), serum magnesium, serum sodium, serum 
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potassium and serum calcium were measured and were all in the normal range. 
Besides the parents, who are second cousins, another couple who are second cousins 
is present in this family; their two children had normal psychomotor development, 
with no convulsions and no abnormalities observed in the laboratory investigations. 
Based on the normal results of the parents, the occurence in sibs, and the 
consanguinity, we presume an autosomal recessive mode of inheritance for the 
isolated renal magnesium loss. 
DISCUSSION 
Commonly magnesium deficiency is caused by disorders affecting the gastrointestinal 
tract or the kidney. A defect in the intestinal absorption of magnesium could be 
excluded in Patient 1. Urinary magnesium excretion can be found as low as 0.2 to 0.4 
mmol/24 hours during magnesium deprivation (Thorèn 1971). 
0-Γ-0 
0—r-0 0-HZf 
0-T-D П-г-O 0JZÍJZÍ 
ϊ 
jz ja G 
ΐΐ 
f O D D 
б Ó 
Fam ν d E 
-Personal ly 
examined 
Figure 3. Pedigree of the family. Arrow (.>) indicates Patient 1; (-) indicates persons personally 
examined. Two pairs of second cousins are present and an autosomal recessive mode of inheritance is 
found. 
In these two patients the urinary magnesium excretion was in the normal range, 
although the serum magnesium level was lowered, pointing to a disturbance of tubular 
reabsorption of magnesium. Rude and Singer (1981) reviewed the different causes of 
renal magnesium wasting causing magnesium deficiency. Hypercalcemia, primary 
aldosteronism, the use of drugs such as cis-platinum, osmotic diuresis and a number of 
48 
different renal diseases causing renal tubular damage could be eliminatedas an 
explanation for the renal magnesium loss in our patients. Except for the brisk tendon 
reflexes, no clinical symptoms possibly related to magnesium deficiency were found. 
Positive Chvostek's and Trousseau's sign were absent, as were muscular weakness and 
incoordination, ataxia, coarse and irregular tremor. ECG and EMG were normal. In 
both patients normal values were measured for parathormone, reflected in the normal 
Tm phosphate. Freeman and Pearson (1966); Milazzo et al. (1981) and Geven et al. 
(1987) have reported isolated renal magnesium loss. None of these reports showed 
serum electrolyte abnormalities apart from hypomagnesemia. An autosomal dominant 
mode of inheritance was demonstrated by Geven et al. (1987). The calcium excretion 
in the different members of these families with hypomagnesemia was lowered. 
In the patients reported here the serum magnesium levels were not as low as in the 
families with the autosomal dominant form. 
In autosomal dominant magnesium loss, not only the renal magnesium threshold was 
lowered but also the TmMg. The hypothesis was proposed that the hypomagnesemia 
increased the calcium reabsorption in Henle's loop. The only slightly lowered 
magnesium level present in the autosomal recessive form apparently had less effect on 
Henle's loop in relation to the calcium reabsorption. 
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SUMMARY 
The influence of magnesium depletion in humans with isolated renal magnesium loss, 
was studied on the renal excretion of prostaglandin Ej, prostaglandin F^, 6-keto-
prostaglandin F,
e
 and thromboxane B2. In animal experiments magnesium depletion 
caused an increased outflow of prostaglandins from the mesenteric arterial bed. In our 
group of magnesium depleted humans there was no increased formation of 
prostaglandin E2, prostaglandin F^, 6-keto-prostaglandin F l e and thromboxane B2 in 
the kidney as reflected by their normal excretion in the urine. 
INTRODUCTION 
Magnesium is the fourth most abundant cation in the human body and the second 
most common in the intracellular fluid. Potassium is the most important cation in the 
intracellular fluid. Potassium depletion in dogs and human beings stimulates renal 
prostaglandin E synthesis [1]. In rats with experimental magnesium deficiency the 
plasma and tissue levels of PGEj, PGF^, 6-keto-PGF1(1 and TXB2 were significantly 
higher than in normals [2]. Recently we studied two families presenting with 
hypomagnesemia due to isolated renal magnesium loss [3]. This offered us the 
opportunity to evaluate the influence of magnesium depletion on the renal excretion 
of prostaglandins in human beings. 
Table 2. Normal renal prostaglandin and magnesium excretion during 
hypomagnesemia. 
Prostaglandin excretion Mag-
6-keto- nesium 
patient sex PGF^ PGEj TXB2 PGF^ excr. 
nmol/24h nmol/24h nmol/24h nmol/24h mmol/24h 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Normal 
values 
Μ η = 20 
F n = 18 
F 
M 
F 
M 
F 
F 
F 
F 
M 
F 
F 
M 
M 
F 
7.90 
10.00 
5.70 
18.00 
6.00 
9.20 
7.80 
7.20 
22.00 
8.10 
10.00 
6.70 
7.6-
33.0 
3.6-
10.0 
1.40 
0.79 
0.11 
0.60 
0.17 
0.16 
0.20 
0.33 
0.84 
0.63 
0.28 
0.35 
0.40-
4.8 
0.07-
0.98 
1.20 
0.84 
1.60 
1.20 
1.40 
0.93 
1.10 
1.60 
2.20 
1.80 
2.00 
1.00 
0.86-
5.3 
0.70-
2.3 
7.10 
4.60 
6.60 
10.00 
6.80 
9.80 
4.80 
9.70 
12.00 
7.80 
7.80 
6.10 
3.0-
8.7 
2.2-
11.0 
4.7 
2.1 
1.7 
4.9 
4.0 
4.0 
3.6 
6.0 
5.0 
5.8 
5.7 
3.2 
2.5-
5.0 
[19] 
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MATERIALS AND METHODS 
Twelve patients with hypomagnesemia due to isolated renal magnesium loss could be 
studied. In each of them analysis of serum and urinary magnesium and also the 
magnesium content of mononuclear cells (mo-Mg) was performed according to 
methods described earlier [4].The urinary excretion per 24 hour was measured of 
prostaglandin Ξ^ (PGE2), prostaglandin F ^ (PGF^), 6-keto-prostaglandin Fla (6-
keto-PGFjJ and thromboxane B2 (TXB2) in all patients and compared with control 
values. 
24-hour urine samples were collected and stored at -20° С until assay for 
prostaglandins. The excretion of PGEj, PGF^, 6-keto-PGFla and TXB2 in the urine 
specimen samples were determined by highly specific radioimmunoassays (RIA) 
according to the procedures previously described [5,6]. In brief, the assays include the 
following steps: to 1 ml urine samples an amount of 17 Bq PG tracer 
{5,6,ll,12,14,15(n)-3H} PGF^ sp.act. 5.92 TBq/mmol, Amersham International pic 
(U.K.) was added, since it could be demonstrated that the addition of a single titrated 
PG was sufficient to monitor the similar procedural losses of the four PGs throughout 
the next steps. The samples were acidified with 0.1 ml I n HCl to pH 3.5, extracted 
with 2x10 ml ethyl acetate and the solvent residue was applied to gel filtration on 
Sephadex G-25. An aqueous, low molecular mass effluent was collected containing the 
PGs with recoveries of {3H}PGF2e between 50 and 70%. The effluent selected was 
applied to specific radioimmunoassay for PGF^ PGE^, 6-keto-PGF1(I and TXB2 and 
the results obtained were corrected for percentage recovery. Cross-reactivity at 50% of 
{3H} PG displacement for the anti-PGF^ antiserum (obtained from Dr. 
H.R.Behrman, Harvard Medical School Boston, Mass., U.S.A.) was 17% with PGF,,,. 
The anti-PGEj antiserum (purchased from Institute Pasteur Production, Paris, France) 
showed 10.5% cross-reaction with PGE! . The anti-6-keto-PGF1(I antiserum 
(purchased from Seragen Inc., Boston, Mass., U.S.A.) cross-reacted 12.8% with PGEj 
, 1.4% with PGEj and 7.4% with PGF^. The other PGs tested (Ε,Ρ,Α,Β) gave values 
of < 0.1% with the antiserum used, including the one directed towards TXB2 
(obtained from Dr. F.A.Fitzpatrick, The Upjohn Company, Kalamazoo, Mich., 
U.S.A.). The РСЕг assay used {5,6,8,ll,12,14,15(n)-3H} PGE2 (Amersham 
International pic, Amersham, U.K.) with a sp.act. of 5.92 TBq/mmol. The tritium 
labeled preparations of the 6-keto-PGFla and the TXB2 assays were 6-keto-
{5,6,8,9,ll,12,14,15-(n)-3H}-PGF1(I and {5,6,8,9,ll,12,14,15-(n)-3H}-TXB2 (sp.act. 6.04 
TBq/mmol), respectively, and were purshased from New England Nuclear Boston, 
Mass., U.S.A. 
Sensitivities of the four assays as defined at B/B0 =0.9 following logit-log 
transformation of the assay data, were 1.4 fmol PGE2 , 8.5 fmol PGF2,,, 10.0 fmol 6-
keto-PGFi,, and 8.4 fmol TXB2 per assay tube. Method blanks were below the 
sensitivity limits. Intra and interassay variabilities were calculated from a urine pool 
stored at -70° С After ten concecutive assays the PGEj determinations showed 6.4% 
and 15%, the PGF^ assay 5.3% and 11%, the 6-keto-PGFi,, assay 7.3% and 9.6% 
and the TXB2 assay 8.1% and 12.5% intra- and interassay variability, 
respectively. 
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Table 1. Values of serum magnesium, erythrocyte magnesium and mononuclear magnesium in the patients 
with isolated renal magnesium loss. In all patients 3 repeated determinations were performed. 
Patient age sex se-Mg mmol/l er-Mg μ £ ^ RBC mo-Mg μβ/οβίΐ mo-Mg μg/mg prot. mo-Mg μg/mg DNA 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
50 
27 
24 
17 
49 
25 
52 
57 
42 
55 
54 
27 
F 
M 
F 
M 
F 
F 
F 
F 
M 
F 
F 
M 
0.34 
0.39 
0.44 
0.61 
0.56 
0.44 
0.43 
0.55 
0.35 
0.41 
0.46 
0.32 
0.50 
0.46 
0.51 
0.61 
0.44 
0.44 
0.44 
0.56 
0.46 
0.35 
0.52 
0.31 
0.36 
0.41 
0.52 
0.65 
0.50 
0.43 
0.59 
0.52 
0.41 
0.37 
0.43 
0.35 
113 
110 
126 
130 
120 
125 
144 
151 
118 
102 
126 
87 
126 
115 
132 
139 
114 
125 
133 
149 
110 
99 
122 
85 
122 
155 
127 
128 
110 
122 
136 
143 
119 
101 
125 
85 
125 
89 
95 
68 
97 
106 
92 
104 
112 
82 
102 
81 
93 
80 
78 
92 
73 
120 
102 
102 
98 
87 
86 
88 
91 
57 
89 
62 
85 
117 
89 
109 
82 
69 
51 
91 
1.18 
1.05 
1.04 
0.96 
0.98 
1.34 
1.29 
1.19 
1.22 
1.15 
1.34 
1.10 
1.34 
1.31 
1.29 
1.18 
0.92 
1.22 
1.10 
1.04 
1.12 
1.21 
1.25 
1.15 
1.49 
0.87 
1.02 
0.88 
0.86 
1.32 
1.19 
1.15 
0.92 
0.94 
0.65 
1.01 
13.1 
9.2 
10.5 
7.5 
10.3 
10.6 
9.9 
12.7 
11.7 
9.0 
11.3 
9.3 
10.6 16.9 
9.1 9.2 
9.9 10.8 
8.7 7.3 
8.0 13.7 
12.1 15.7 
10.9 11.9 
10.6 14.7 
9.0 10.5 
9.5 9.0 
8.8 6.5 
9.4 11.6 
mean 0.44 0.47 0.46 121 121 123 96 92 83 1.15 1.18 1.03 10.4 9.7 11.5 
sd 0.09 0.08 0.09 17 18 18 15 13 20 0.13 0.12 0.23 1.6 1.1 3.3 
Normal values 0.75 - 1.00 125 - 191 49 - 148 0.75 - 1.34 6.5 - 18.3 
η = 56 η = 56 η = 56 η = 56 
Statistical methods 
Wilcoxon's signed rank test was used for detection of differences between determined 
values and Spearman's rank correlation coefficients to detect a possible relationship 
between serum and erythrocyte magnesium content. Results were considered to be 
significant when p<0.05. 
RESULTS 
As shown in table 1 all patients had lowered levels of serum magnesium. Serum 
concentrations of sodium, potassium, calcium, phosphate, creatinine, urea, and PTH 
were within normal ranges in all patients. Mean er-Mg was decreased compared to 
the control values (p< 0.01). These control values were obtained from 56 normal 
adults (females and males showed no significant difference between both sexes). 
Figure 1 shows all se-Mg and corresponding er-Mg values. There was a good 
correlation between se-Mg and er-Mg (r=0.79, p=0.002). The mean content of 
mononuclear magnesium expressed as μg Mg/mg protein was significantly lower than 
Serum Mg (mmol/1 ) 
0.60 
050 
ОАО 
0.30 
Patient 
o 1 
• 2 
• 3 
Δ 4 
A 5 
• 6 
+ 7 
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• 10 
• 11 
x 12 
Δ Δ 
+ 
* · ν 
Α Ο 
D τ * 
А Ш· + 
• * + 
* 
100 
— ι 1 1 1 г— 
120 V.0 160 
Erythrocyte Mg l>jg/gr RBC) 60 
Figure 1: Senim-magnesiunt levels with corresponding erythrocyte magnesium values show a good 
correlation (r=0.79, p=0.002 ). 
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control values (ρ < 0.05). No lowered mo-Mg was found when the magnesium content 
of mononuclear cells was expressed as fg Mg/cell and μg Mg/mg DNA. Although the 
serum magnesium concentration was decreased, the urinary excretion of magnesium 
was within the normal range pointing to a renal reabsorption defect for magnesium. 
In these magnesium depleted patients the renal excretion of the four measured 
prostaglandins, PGEj, PGF^, 6-keto-PGFla and TXB2, was in the normal adult range 
(table 2). 
DISCUSSION 
It is obvious that potassium depletion in the dog, in the rabbit and also in the human 
stimulates the renal PGE^ synthesis [7]. So it was tempting to study the influence of 
depletion of magnesium, as the second most intra-cellular cation in the human, on the 
renal prostaglandin excretion. All our patients had distinctly lowered serum 
magnesium concentrations. As was already observed in the dogs [4] erythrocyte 
magnesium content appears to reflect better the body magnesium stores than 
mononuclear magnesium levels. In our patients a normal value of urinary 
prostaglandin excretion was demonstrated. This is in contrast to the experimental data 
of Nigam et al [2]. They measured the plasma and tissue concentrations of 
prostanoids PGEj, PGF^, 6-keto-PGFia and TXB2 in normal rats and in rats 
receiving a magnesium deficient diet for 12 weeks. The mean values of the plasma 
and tissue levels of the four prostanoids were significantly higher in the magnesium 
deficient rats. Their approach, however, can be criticized. Plasma and tissue levels of 
prostanoids are considered not to be meaningful as indices of in vivo product 
formation [8,9,10]. The primary compounds have very short biological half-life and the 
possibility of ex-vivo formations by a varity of stimuli is great. The invasive sampling 
via a catheter already results in an artifactual release of PGI2 and TXB2 [8,11]. 
Another explanation for the discrepancy between their and our results could be the 
species difference and different degree or duration of the magnesium deficiency. In 
rats on a low magnesium diet the PGEj, 6-keto-PGF1(1 and TXB2 outflow from 
perfused isolated mesenteric arterial bed was significantly increased compared to 
controls [12]. These results point in the same direction as these reported by Nigam et 
al. [2]. The assumption has been made that the urinary excretion of the four prostag­
landins studied, reflects mainly renal biosynthesis. No definite conclusions however, 
have been reached. The prostaglandins PGE^ and PGF^ have been the most 
extensively studied. The renal medullary interstitial cells and collecting tubles are the 
major sites of PGEj and PGF^ synthesis. After intravenous injection in man no intact 
labelled PGE2 could be recovered from the urine [13]. Following their synthesis PGEj 
and PGF^ can be subjected to metabolism [14] and transport to the venous 
circulation [15]. In addition the urinary excretion is influenced by urinary pH [16,17] 
and flowrate [16,17,18]. With these restrictions in mind we were unable to 
demonstrate an effect of magnesium depletion on the renal biosynthesis of 
prostaglandins in our group of patients with magnesium deficiency. 
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SUMMARY 
Reference values for magnesium and potassium contents of mononuclear cells and 
erythrocytes were estimated in cord blood and in children form infancy through 
adolesence. No differences were detected between results for boys and girls. The 
mononuclear magnesium content was independent of age and was within the adult 
range of values. No significant correlation was shown between magnesium in serum 
and in mononuclear cells. Mononuclear potassium also showed no age-related 
differences. The correlation between magnesium and potassium contents in 
mononuclear cells was significant; however, the correlation was lower when the 
magnesium and potassium contents were expressed in terms of protein content: 
micromoles or millimoles per gram of protein, respectively. The concentration of 
magnesium in erythrocytes was significantly lower in cord blood and during the first 
month of life, compared with that at older ages, and showed no significant correlation 
with serum magnesium. The concentration of erythrocyte potassium was independent 
of age and showed a low but significant correlation with erythrocyte magnesium 
content. 
INTRODUCTION 
Magnesium and potassium are the main intracellular cations, with only small 
percentages of their total amounts in the body being located in extracellular fluid. 
After Baron and Ahmed [1] advocated the use of leukocytes for measurements of 
intracellular ions, an increasing number of papers have proposed the use of 
magnesium content of mononuclear cells as an index of intracellular magnesium [2]. 
Senim Magnesium (mmol/L)-
1.0 
0.8 
0.6 
* . + * 
t * * jjf 
*** * 
*
 ± * + 
+ * 
C B 0 1 2 4 8 16 3 2 6 4 1 2 8 2 5 6 
Age (months) 
Figure 1. Serum magnesium versus age. CB is cord blood. 
64 
Paunier et al. [3], investigating the fetal-maternal relationship of intra- and 
extracellular magnesium and potassium concentrations, found a significant lower 
magnesium concentration in erythrocytes of cord blood in comparison with the 
maternal erythrocytes. The potassium concentration in cord blood erythrocytes, 
however, was higher than in maternal erythrocytes. The good correlation of 
magnesium and potassium in lymphocytes and erythrocytes in both cord and maternal 
blood showed remarkable similarity. But Abraham and co-workers [4] reported the 
absence of a significant correlation of magnesium and potassium in lymphocytes and 
erythrocytes. 
The aim of this study was to establish reference values of magnesium and potassium 
in erythrocytes and mononuclear cells in comparison with serum levels in childhood 
from cord blood through adolescence. Investigation into the possible age-dependancy 
of intracellular magnesium and potassium values shows considerable gaps. Without 
reference values, individual data obtained in children with suspected magnesium 
deficiency or magnesium loosing nephropathy cannot be put into context. This study 
also supplies new data to the relation of magnesium and potassium in mononuclear 
cells and erythrocytes. 
MATERIALS AND METHODS 
Samples approximately 5 - 10 ml of heparinised blood were taken during venipuncture 
from subjects whose conditions had no known relation to hypomagnesemia, lowered 
concentrations of potassium in serum or magnesium- or potassium deficiency. Most 
of the patients in the younger age groups (I and II) were hospitalized; the older ones 
(Groups III and IV) were mostly outpatients. Previously measured concentrations of 
serum potassium and magnesiumin these subjects in Group III and IV were within the 
normal ranges. All patients had normal oral feeding. Ten milliliter cordblood was 
taken from neonates born vaginally after uneventful pregnancies and births. 
We grouped the samples as follows: Group I, 8 samples of cordblood; Group II, 8 
samples from the first month postpartum; Group III, 15 samples from ages between 1 
and 6 months; and Group IV, 57 samples from ages six to 200 months (6-12 months, 
eight samples; 12-36 months, 12 samples; 36-72 months, 13 samples; 72-120 months, 
10 samples; 120-200 months, 14 samples). Every child in this study was analysed once. 
All groups contained as many boys as girls, or differed by no more then one in groups 
with an unequal number of samples. Thus we could evaluate the influence of age and 
sex on the reference values. 
Laboratory methods 
Magnesium was measured by atomic absorption spectrophotometry (Perkin Elmer 
5000, Norwalk CT). Other measurements were done by routine laboratory methods. 
In 17 samples, taken at random, the total amount of leukocytes in the venous blood 
was counted (Coulter Counter, Coulter Electronics ltd., Luton, England) and 
identified microscopically in a smear. Mononuclear cells were isolated according to 
Elin and Johnson [5]. The heparinised blood was diluted with equal volumes of 
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buffered saline and glucose solution (BSG; containing 8.1 g NaCl, 1.53 g 
NaHP0 4 .2H 20, 0.194 g NaH 2 P0 4 .H 2 0 and 2 g glucose per litre with an osmolality of 
290 mosm/kg and a pH 7.4 adjusted with NaOH). The cord blood was diluted with 20 
mL of BSG because of the high hemoglobin levels and viscosity. Then, the mixture 
was carefully layered onto Ficoll-Paque (density 1.077 kg/L) and centrifuged at 400 χ g 
for 35 min. The interfase was collected, washed in BSG, and centrifuged at 400 χ g for 
10 min. To the pellet we added 4.5 mL BSG and counted the leukocytes. A 
paraformaldehyde fixation in a cytospin preparation was made and the 
Table 1. Reference values (highest, lowest and (median)) for the various age groups. 
Group 
sc-Mg 
mmol/L 
mo-Mg 
fmol/cell 
μπιοί^ prol 
mmol/g DNA 
mo-K 
fmol/cell 
mmol/g prot 
mmol/g DNA 
mo-Prolein 
pg/ccll 
mo-DNA 
pg/ccll 
er-Mg 
μπιοί^ RBC 
er-K 
mmol/g RBC 
I 
(η = 8) 
0.64-0.77 
(0.75) 
2.96-6.50 
(4.04) 
42.5-49.6 
(46.3) 
0.43-1.05 
(0.54) 
18.3-75.6 
(35.4) 
0.29-0.51 
(0.40) 
2.92-12.13 
(4.71) 
63.6-151.6 
(86.6) 
6.0-9.0 
(7.9) 
5.04-5.54 
(5.28) 
0.23-0.27 
(0.24) 
II 
(η = 8) 
0.70-1.15 
(0.87) 
2.96-7.00 
(6.10) 
16.3-52.1 
(35.6) 
0.35-1.08 
(0.49) 
19.3-74.2 
(51.4) 
0.25-0.56 
(0.32) 
2.28-11.23 
(4.83) 
56.9-297.0 
(158.6) 
6.5-15.4 
(8.4) 
4.67-5.77 
(5.45) 
0.20-0.27 
(0.25) 
III 
(η = 14) 
0.78-1.04 
(0.87) 
2.42-5.79 
(4.08) 
33.3-50.4 
(40.8) 
0.37-0.85 
(0.51) 
25.8-63.6 
(34.3) 
0.21-0.68 
(0.36) 
2.82-10.31 
(4.31) 
49.6-158.3 
(106.7) 
5.3-10.4 
(8.1) 
6.08-8.77 
(7.29) 
0.25-0.29 
(0.26) 
IV 
(η = 57) 
0.65-0.99 
(0.89) 
1.38-7.75 
(3.63) 
22.1-76.3 
(37.1) 
0.12-0.97 
(0.47) 
20.2-68.4 
(32.4) 
0.21-0.53 
(0.33) 
2.67-8.56 
(4.13) 
54.1-205.0 
(98.3) 
5.2-11.4 
(7.8) 
5.23-8.08 
(6.42) 
0.21-0.30 
(0.21) 
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viability of cells was checked by staining with tryptan blue [6]. Exactly 4 mL of the 
cellsuspension was centrifuged at 600 χ g for 10 min. To the pellet we added 700 ßh 
of de-ionised water and sonicated the sample three times, 15 s each at 45 s interfal. 
The tubes were cooled in ice. The magnesium content of the lysate was determined 
with atomic absorption spectrophotometry using lanthanoxide [5]. Protein was 
measured according to Lowry [7]. DNA was estimated with use of DAPI (4,6 
diamidino-2-phenylindole.2HCl) [8]. From the counted total number of mononuclear 
cells in the known volume of venous blood and in the cell suspension, we calculated 
the percentage of harvested mononuclear cells. Magnesium was expressed as fmol/cell, 
μπιοΐ/g of protein and mmol/g of DNA. The potassium content of the lysate, 
measured by flame photometry was expressed as fmol/cell, mmol/g of protein and 
mmol/g of DNA. 
After centrifugation, erythrocytes were collected and washed four times in CsCl (155 
mmol/L, osmolality 290 mosmol/kg) [9]. We then lysed 100 ßL of packed cells in 400 
ßL of de-ionised water. We suspended 100 ßh from this lysate in an Eppendorf cup, 
evaporated the liquid and weighted the residue. The lysate was frozen until! time of 
assay. Magnesium and potassium were expressed as micromoles or millimoles, 
respectively, per gram of erythrocytes dry weight. 
Statistical methods 
We used Spearman's rank correlation coefficients to detect possible relationships 
between different variables. The Kruskal-Wallis test [10] was used to detect possible 
differences between the age groups for all analytes. Control for normality was 
performed according to Stephens [11], and we used Wilcoxon's two sample test to 
detect possible differences between boys and girls. Results were considered to be 
significant when ρ < 0.05. 
RESULTS 
Microscopic identifying and counting of the harvested cells gave: 1% ± 2(mean + 
SD) polynuclear cells, 85% ± 6 lymphocytes, and 13% ± 6 monocytes. From the total 
amount of mononuclear cells in the venous blood, 56 ± 13%(mean + SD) were 
harvested by this Ficoll-Paque isolation technique. The viability test with tryptan blue 
showed 95-98% vital cells. 
Because significant differences in any parameter were absent (Kruskal-Wallis test: 
p>0.05) in all age-groups above the age of six months, all children older than six 
months were combined into one group (IV). 
Table 1 lists the reference values of the different groups. Because of the limited 
number of samples in Groups I - III, we list the highest, lowest and median value. 
Serum magnesium (fig.l) in cordblood (Group I) was significantly lower than in 
samples from age groups older than one month (Group III and IV), with p< 0.01 for 
both groups, but showed no difference from results of samples collected during the 
first month post partum (Group II). By the first month, there was a wide spread in 
the results and a considerable increase in serum magnesium to a median value of 
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0.87 vs 0.75 mmol/L in cord blood. 
Figure 2 a-c shows concentrations of magnesium in mononuclear cells (mo-Mg) for 
the whole population versus age. mo-Mg expressed as fmol/cell and mmol/g of DNA 
was not significantly different between all groups; but when expressed as mmol/g of 
protein, mo-Mg of Group I was significantly higher than that in Group III and IV 
(p=0.015 respectively p<0.01), probably because of a smaller range and lower median 
cell protein content in Group I. For all samples, mo-Mg in fmol/cell correlated very 
well with mo-Mg expressed as mmol/g of DNA (r=0.82, P<0.01), but no significant 
correlation was found between mo-Mg was expressed as fmol/cell or mmol/g of DNA 
versus mmol/g of protein. mo-Mg expressed in all three ways had no significant 
correlation with se-Mg. 
Erythrocyte magnesium content ( figure 2d) was significantly lower in Groups I and II 
in comparision with Groups III and IV (p<0.01 for all instances). In contrast to the 
magnesium concentrations in serum, which rose during the first month post partum, 
the erythrocyte magnesium content increased between one and six months of age. 
This is reflected by the median erythrocyte magnesium content of 5.28 and 5.45 
Mmol/g RBC in Groups I and II respectively, increasing to 7.29 μιηοΐ/ΐ RBC in Group 
III. 
Table 2. Correlation between magnesium and potassium in mononuclear 
cells (both expressed per cell, protein and DNA content) and erythrocytes. 
Mononuclear cells 
Erythrocytes 
fmol/cell 
μπιοί^ protein 
mmol/g DNA 
цто1( $ mmol/g 
RBC dry weight 
r 
0.65 
0.32 
0.73 
0.2S 
Ρ 
0.0001 
0.0042 
0.0001 
0.0170 
We also studied mononuclear cell potassium (mo-K) in the different age groups but 
found no changes with age. The relation between mo-Mg and mo-K is presented in 
figure 3a and table 2. A remarkable lower correlation coefficient between these 
cations existed when mo-Mg and mo-K were expressed in mmol/g of protein, 
compared with the expression in fmol/cell and mmol/g of DNA (table 2). 
Both mo-Mg and mo-K content showed significant correlations with mononuclear 
protein content (r=0.73, p=0.01 and r=0.50, p=0.01 respectively), pointing to the 
influence of cell composition and size on magnesium and potassium content of 
mononuclear cells. On the other hand, we detected no significant correlation of mo-
Mg and mo-K content with the DNA content of the cells (r= 0.08, p=0.31 and 
r=0.01, p=0.56 respectively). 
er-K showed no significant differences in all groups. 
er-Mg and er-K showed a positive but low correlation coefficient (r=0.28 p<0.05)(fig. 
3b and table 2). 
A significant correlation between mononuclear cells and erythrocytes for both 
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magnesium and potassium was absent. 
DISCUSSION 
Although reference values for mononuclear magnesium and potassium have been 
collected in adults, no data are known regarding childhood. Only Paunier et al. [3] 
investigated the fetal-maternal relationship of intra- and extracellular magnesium and 
potassium concentrations. The cord blood data in this study were comparable to those 
presented by Paunier et al. [3] but the range that we found was smaller. From 
published data for adults [2,12,13,14,15,16], the mo-Mg content of children appears to 
be in the same range as reported for adults (2.00 - 4.83 fmol/cell and 36.6 - 66.8 
μπιοί^ of protein) [12]. Our results for mo-Mg expressed as mmol/g of DNA are a 
little higher than reported for adults (0.25- 0.57) [16], whereas mononuclear DNA 
Mononuclear Magnesium (mmol/g DNA) 
0 . 9 
0 . 7 
0 5 
» · -
0 3 
0.1 - -
2 4 6 8 10 12 14 
Мпіюпш \LdT Polawium (mmol/g DNA) 
Ptythrocylc Magnesium (μηιηΐ g RBC dry wughl) 
8 
7 
6 
5 
0.16 0 20 0 24 0 28 0 3 2 
kr/lhnxytc Potassium (mmol g RBC iìiy weight) 
Figure 3. Correlation of magnesium and potassium content in (a) mononuclear cells (r=0.82 p<0 01) 
and (b) erythrocytes (r=0.28, p<0.05) 0, cord blood. 
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contents were in the same range. As Elin et al. [12,16] have pointed out, expressing 
mononuclear magnesium in terms of protein content leads to significant problems. We 
agree with Elin and Hosseini [16] that, because of the considerable differences in 
cellular protein content and the wide ranges in cell size, which possibly lead to 
fortuitously noticeable differences between age groups, expression in fmol/cell or 
mmol/g of DNA is preferable. The conclusion that age does not influence 
mononuclear magnesium content leaves the expression in terms of protein, out of 
consideration. Like most other authors [4,5,12-15] except Ryzen et al.[17], we detected 
no correlation for magnesium between serum and mononuclear blood cells. Only a 
few data are available about erythrocyte magnesium in childhood [3,18,19]. Besides 
the wide range shown in all papers, every author uses an other unit to express the 
erythrocyte magnesium amount. Table 3 shows a survey of these data, with a 
conversion into the unit(-type) used by us, based on the assumption of a protein 
content of 371 g/L and dry weight 402 g/L of erythrocytes, for adult erythrocytes 
[20,21]. In cord blood and during the first weeks of life, the mean corpuscular volume 
of erythrocytes is higher than in adults [25], which effects total protein content and dry 
weight/cell. We prefer, however, to relate the erythrocyte magnesium content to grams 
of erythrocytes dry weight because two major sources of error associated with the 
usual technique by which the magnesium content is related to the the original volume 
of packed cells [9]. First, variations in the quantity of trapped extracellular fluid 
should be taken into account; secondly, because of the extreme viscosity of packed 
cells, accurate quantitative pipetting is almost impossible. 
The physiological meaning of this way of expression (дтоі/g of erythrocytes, dry 
weight), however, is doubtful because the erythrocytes in infants younger than one 
month of age have a higher mean corpuscular volume than those in older infants and 
children. Therefore, the number of erythrocytes per gram erythrocytes dry weight is 
lower in this age group, which contributes to the lower magnesium content in Groups 
I and IL 
Table 3. Erythrocyte magnesium content reported in the literature and this study. 
adults 
[13] 
[18] 
[23] 
[24] 
[25] 
units 
nmol/mg prot. 
mmol/L RBC 
mmol/L RBC 
mmol/L RBC 
μ£/β RBC 
dry weight 
mean ± 2 sd 
6.37-9.57 
1.43-2.99 
1.69-2.99 
1.71-2.95 
125-191 
μτηο\/ζ RBC 
(dry weight) 
2.38-3.54 
3.54-7.56 
4.21-7.56 
4.25-7.33 
5.21-7.96 
children > 6 months 
[18] mmol/L RBC 1.53-3.69 3.79-9.17 
This study (range) 5.23-8.08 
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The relationship of intracellular magnesium and potassium in humans was investigated 
in three studies [3,4,13], one of which [3] studied cord blood. Mononuclear magnesium 
and potassium were highly correlated in adult and cord blood mononuclear cells in 
two of these studies [3,13] but not in the other [4]. Our study confirms that this 
correlation is real and exists not only in mononuclear cells of adults and cord blood 
but also in mononuclear cells of children. 
Determination of the reference range for different age groups of children will allow 
meaningfull studies in disorders of potassium and magnesium metabolism in 
childhood. 
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SUMMARY 
In experimental deficient dogs data were obtained of serum magnesium and 
mononuclear, erythrocyte, bone and muscle magnesium amounts, before and during 
deficiency state and in half of the dogs after restoration of the serum magnesium 
level. In each dog 6, respectively 7 measurements were performed. The results showed 
a significant decrease of serum, erythrocyte and bone magnesium during and at the 
end of the magnesium deficiency. Highly positive correlation coefficients for serum 
and erythrocyte magnesium were found and positive correlation was shown for 
erythrocyte and bone magnesium amounts. No decrease of the magnesium level in 
muscle and mononuclear cells was shown during and at the end of magnesium 
deficiency, but significant rise of muscular magnesium was found after normalisation 
of serum magnesium. In magnesium deficiency state erythrocyte magnesium levels 
appeared to be a better reflection of the body magnesium stores than mononuclear 
cells. 
bo Mg 3600 η 
se Mg 0.75 
τ 1 1 г 
20 40 
ι 1 1 г 
60 80 100 
Days 
Figure 1. The total experimental period of dog 4. 
Magnesium in se-Mg is expressed in mmol/1, mo-Mg in μ£/π^ protein, er-Mg in μg/gr RBC dry weight, 
mu-Mg in μg/gг dry weight and bo-Mg in μg/gr dry weight. 
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INTRODUCTION 
Magnesium is distributed in three major compartments of the body: 65% in the 
skeleton, 34% in the intracellular space and only 1% in the extra-cellular fluid. In 
their seminal study in man about body magnesium stores, Alfrey et al. [1] concluded 
that bone and extracellular fluid magnesium are the major magnesium pools 
decreased during magnesium depletion. There was a highly significant correlation 
between the levels of serum and bone magnesium (se-Mg and bo-Mg respectively). 
Muscle magnesium content did not reflect total body magnesium [1]. 
Baron and Ahmed [2] and Ryan et al. [15] advocated to use peripheral blood 
lymphocytes for the estimation of intracellular electrolytes. During experimental Mg 
deficiency in rats the magnitude of the Mg loss from the lymphocytes was similar to 
that of cardiac and skeletal muscle tissue [16]. 
The aim of our study was to reevaluate the significance of se-Mg and magnesium 
content of erythrocytes (er-Mg ), muscle (mu-Mg),bone (bo-Mg) tissue and also of 
mononuclear cells (mo-Mg), for the monitoring of total body magnesium in an 
experimental study of magnesium depletion in the dog. The size of the animal allowed 
us repeated sampling in the same animal. In agreement with most data bo-Mg is 
closely related to the extracellular magnesium content while mu-Mg and mo-Mg 
remain relatively stable. The magnesium content of erytrocytes showed a positive 
correlation with both se-Mg and bo-Mg. Futher studies of the subcellular distribution 
of magnesium in the erytrocyte should provide the required knowledge for application 
in clinical studies. 
MATERIAL AND METHODS 
Ten young adult beagles, housed in individual cages, were fed with a magnesium 
deficient diet and de-ionised water. Table 1 and 2 show the composition of the diet 
Table 1. Composition of the diet without supplemented 
MgO, containing 170 ppm Magnesium. 
Ingredient: 
Casein 
Corn starch 
Dextrose 
Lard 
Soybean oil 
Cellulose 
Dicalcium phosphate 
Calcium carbonate 
NaCl 
dl-Methionin 
KH2PO4 
Vitamin and trace element mixture 
Choline chloride 
% 
32.0 
28.0 
26.0 
4.0 
1.0 
3.0 
1.67 
1.67 
0.43 
0.20 
1.06 
0.77 
0.20 
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that contained 170 ppm magnesium. During the first 4 weeks, the magnesium intake 
was gradually lowered weekly from 4.5 via 4.0 and 3.5 to 3.25 mg magnesium/kg body 
weight per day. In 5 dogs the magnesium intake was increased by supplementation 
with MgO (12mg Mg/kg.day) after 112 days. Each week blood was drawn for 
measurement of magnesium, sodium, potassium, calcium, phosphate, ureum, 
creatinine, hemoglobine and leucocytes. When the se-Mg levels had dropped to about 
0.5 mmol/1 (normal 0.70-1.1) [14] samples were taken and data were collected 3 times 
with intervals of one week. Thereafter magnesium deficient diet was maintained and 
one month later blooddrawing and biopsies were repeated twice with one week 
interval. 
In 5 dogs in whom the intake of magnesium had been restored, analyses of se-Mg, 
mo-Mg, er-Mg and a seventh bone and muscle biopsy were done, one week after 
normalisation of se-Mg levels. 
Blood was drawn from the dog in a conscious state while biopsies were taken during 
narcosis with droperidol/fentanyl followed by pentobarbital. Bonebiopsy was a 
punchbiopsy with a diameter of 0.5 cm from the iliac crest, carefully selecting a new 
biopsy site at each puncture. Muscle biopsy was taken from the musculus gracilis. 
Table 2. Vitamins and trace elements added to 
one kilogram of the magnesium deficient diet. 
Vitamin A 
Vitamin D3 
Vitamin K3 (menadione) 
Vitamin E 
Thiamine hydrochloride 
Riboflavin 
Pyridoxine HCl 
Niacin 
d-Ca-Pantothenate 
Vitamin BJJ 
Biotin 
Folic acid 
Inositol 
Iron subcarbonate (57% Fe) 
Copper carbonate (55% Cu) 
Manganous oxide (62% Mn) 
Zinc oxide (78% Zn) 
Na Selenite (45% Se) 
Ca(I03)2 
15000 
1500 
2.5 
92 
20 
20 
15 
40 
40 
40 
200 
5 
200 
180 
30 
100 
71 
400 
1.0 
IU 
IU 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
με 
μβ 
mg 
mg 
mg 
mg 
mg 
mg 
μβ 
mg 
LABORATORY METHODS 
Mg was measured by atomic absorption spectrophotometry (Perkin Elmer). Other 
measurements were done by routine laboratory methods. Isolation of mononuclear 
cells was performed according to Elin and Johnson [7]. Ten ml heparinised blood was 
diluted with equal amounts of a buffered saline and glucose solution (BSG), carefully 
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layered on Ficoll-Paque (brought on a densitiy of 1070) and centrifuged at 400 χ g for 
35 minutes. The interface was collected, washed in BSG and centrifuged at 400 χ g for 
10 minutes. To the pellet 4.5 ml BSG was added and leucocytes were counted on a 
Coulter Counter (Coulter Counter Electronics). A cytospin preparation was made and 
the viability of cells was chequed by a supravital staining with tiyptan blue. Exactly 4 
ml of the cell suspence was centrifuged at 600 χ g for 10 minutes. To the pellet 700 
μΐ de-ionised water was added and sonicated for 3 χ 15 seconds with 45 seconds 
intervals. 
The magnesium content of the lysate was determined with atomic absorption 
spectrophotometry. Protein was measured according to Lowry. DNA was estimated 
with DAPI (4,6 diamidino-2-phenylindole.2HCl) [11]. Magnesium content was 
expressed as μg/mg protein and as μg/ mg DNA. 
Erythrocytes: after centrifugation erythrocytes were collected and washed 4 times in 
CsCl(155 mmol/1, osmolarity: 290 mosmol/kg) [22]. Then 100 μΐ packed cells were 
lysed in 400 μΐ de-ionised water. From this lysate 100 μΐ was suspended in separate 
cups, dried and weighted. The lysate was frozen untili time of assay. Magnesium 
content was expressed as μg/g. RBC (dry weight). 
After the biopsy was taken, the bone was cleaned from blood rests in HjOj 3% for 1 
minute, the samples rinsed with de-ionized water, frozen at -70° C, freeze-dried in 
vacuo and pulverised. After hydrolysis with concentrated HNC^-HClO,,, the obtained 
solution was supplemented with de-ionized water and the magnesium concentration 
measured [3]. Magnesium was expressed as μg/g.dгy weight. 
Muscle was handled exactly as bone except the H 2 0 2 procedure. The magnesium 
content was also expressed as μg/g.dry weight. 
Table 3. Mean and standard deviation of the measurements in all dogs before and at 
the end of the magnesium deficiency period. 
n=10 
se-Mg 
mo-Mg μg/mg prot. 
mo-Mg μg/mg DNA 
er-Mg 
mu-Mg 
bo-Mg 
before 
mean (sd) 
0.77 (0.06) 
1.15 (0.07) 
41 ( 16 ) 
212 ( 16 ) 
871 ( 99 ) 
2635 (539 ) 
end 
mean 
0.45 
1.09 
32 
106 
727 
1896 
(sd) 
(0.11) 
(0.17) 
( 1 5 ) 
( 1 9 ) 
(162) 
(389) 
Ρ 
<0.01 
ns 
ns 
<0.01 
ns 
<0.01 
Magnesium in se-Mg is expressed in mmol/l, mo-Mg^ g/mg protein and in μg/mg DNA, er-Mg in 
μg/gr RBC dry weight, mu-Mg in μg/gr dry weight and bo-Mg in μg/gr dry weight. 
Statistical methods 
We used Wilcoxon's signed rank test to detect differences between different 
determined values and Spearman's rank correlation coefficients to detect possible 
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relationships between different variables. Results were considered to be significant 
when ρ < 0.05. 
RESULTS 
Between the dogs there are differences in the rate of lowering of the se-Mg 
concentration. The second measurement of mo-Mg, er-Mg, mu-Mg and bo-Mg was 
undertaken in 5 dogs between 35-40 days and in the others between 50-63 days after 
the start of magnesium deficient diet. Sodium, potassium, calcium, ureum and 
creatinine levels remained within the normal range in every dog during the entire 
experiment. Phosphate levels were slightly lower at the end of the experiment in most 
dogs but remained close to the lower range of normal values. Figure 1 shows the 
results in one dog. 
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Figure 2. se-Mg (mmol/I) and er-Mg ^g/gr RBC) show good correlation. 
No significant difference for bone, muscle, erythrocyte, mononuclear cell content and 
serum magnesium between the measurements after 35-40 days and 1 month later was 
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observed. Table 3 presents the data of analyses performed before and at the end of 
magnesium deficiency. Data before and during magnesium deficiency presented as the 
mean of the measurements 2 - 6 are shown in table 4. The results after normalisation 
of se-Mg are a cumulation of 5 determinations. In table 5 data are shown one week 
after supplementation of magnesium. In table 6 median individual correlation 
coefficients and their range for these compared data are listed. 
Mononuclear cells 
There was no significant change in mo-Mg during the periode of Mg deficiency while 
mo-Mg ^g/mg.protein) showed significant rise after supplementation. Individual 
correlation coefficients for mo-Mg showed a very wide range and the medians of the 
individual correlation coefficients are mostly weak. In none of the dogs a significant 
positive correlation between mo-Mg/mu-Mg and mo-Mg/bo-Mg could be 
demonstrated. 
Erythrocytes 
In figure 2 se-Mg is plotted against er-Mg. A significant lowering during deficiency 
and a significant rise after normalisation of se-Mg was demonstrated (table 3,4 and 5). 
D U I 1С 1 
3600 η 
3 0 0 0 -
2 A 0 0 -
1 8 0 0 -
1 2 0 0 -
•ly ι ,uy /y 
Dog 
O l 
»2 
• 3 
¿4 
»5 
• 6 
• 7 
v8 
α9 
•10 
ν ν 
u i y 
+ 
л 
# 
wciyi i i/ 
ν 
+
 • * 
+ • 
i 
ψ * 
* i 
τ 
* 
• 
ο 
• ο • + 
Δ • 
• · 
ι -
0 
Δ 
Α 
Ο 
V 
7 » 
* 
1 
+ 
• 
Ι 
50 100 150 200 2 5 0 
E r y t h r o c y t e M g l ^ g / g r - R B C ) 
Figure 3. Bo-Mg (μξ/ζΐ dry weight) and er-Mg (ng/gr RBC) have a low correlation. 
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A high correlation was shown for er-Mg and se-Mg (table 6 and figure 2). Six dogs 
had significant individual correlation coefficients (0.81-1.0; p<0.05) and in the others 
it was also positive. Low positive median individual correlation coefficient was present 
for er-Mg and bo-Mg (fig.3, table 6). 
Muscular magnesium 
The muscular magnesium content of Mg did not drop significantly during the 
deficiency state but raised significantly after normalisation of se-Mg (table 3,4 and 5). 
Individual correlation coefficients between mu-Mg/er-Mg and mu-Mg/bo-Mg were not 
significant in any of the dogs and the median showed very wide ranges (table 6). 
Bone magnesium 
Among the dogs, bone magnesium contents showed a wide range at the beginning of 
the experiment (3479 - 1895 ДІ/^Г. dry weight) when se-Mg was normal. In the dogs 
Bone Mg (/ig /gr dry weight 
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Figure 4. Bone magnesium content of all dogs before (biopsy 1) and during the magnesium deficiency 
(biopsy 2-6). 
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Table 4. Mean and standard deviation of the measurements in all dogs before and 
during the magnesium deficiency expressed as the mean of the values found in the 
biopsies 2-6. 
n=10 before mean 2-6 
se-Mg 
mo-Mg pg/mg prot. 
mo-Mg μg/mg DNA 
er-Mg 
mu-Mg 
bo-Mg 
mean 
0.77 
1.15 
41 
212 
871 
2635 
(sd) 
(0.06) 
(0.07) 
( 1 6 ) 
( 1 6 ) 
( 9 9 ) 
(539) 
mean 
0.46 
1.09 
41 
112 
760 
2114 
(sd) 
(0.05) 
(0.07) 
( 2 2 ) 
( 2 2 ) 
( 8 2 ) 
(209) 
<0.01 
<0.05 
ns 
<0.01 
ns 
<0.01 
Magnesium in se-Mg is expressed in ттоШ, mo-Mg: μgιΊng protein and in μg/mg DNA, cr-Mg in 
μg/gr RBC dry weight, mu-Mg in μg/gr dry weight and bo-Mg in μg/gr dry weight. 
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Figure 5. Bo-Mg (\igfff dry weight) and se-Mg (mmol/l) have a low correlation. 
with high bo-Mg lowering took place in the first 30-50 days of the deficiency period, 
but dogs with low bo-Mg showed only a slight decrease of bone magnesium content 
during the entire deficiency period (fig.4). In figure 5 bo-Mg is plotted against er-Mg. 
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Median correlations of se-Mg and er-Mg or bo-Mg are positive but the range of 
individual correlation coefficients is wide (fig. 3, 5; table 6). 
DISCUSSION 
Though all dogs developed depressed se-Mg levels and one or more signs of 
magnesium deficiency (ragged hair, hypotonia of behind legs, anorexia or slight weight 
loss), we were unable to find a drop in muscular or in lymphocyte magnesium content 
but a significant lower bo-Mg. Even in severe and prolonged magnesium deficiency 
Cronin et al. [5] established only modest lowering of muscle magnesium content in the 
dog, with means that muscle cells and lymphocytes must have protective mechanisms 
against intracellular magnesium deficiency. In patients and healthy men contradictory 
data have been reported about the relationship between the amount of muscular and 
mononuclear magnesium [6,17,19]. Recently Wallach [20] reviewed magnesium 
exchangeability in magnesium deficiency and reported about the very low 
exchangeable bone magnesium in vivo of 1-2% and a decrease of bone magnesium 
content of 17% in magnesium deprived dogs. The wide range of the bo-Mg levels 
before the start of the Mg deficiency indicate that individual measurements of bone 
magnesium content have limited applicability for the detection of intracellular 
magnesium deficiency. In contrast with Cohen and Kitzes [4] who found a very good 
correlation between se-Mg and bo-Mg in Mg deficient patients, we were unable to 
confirm this in Mg deficient dogs. 
Alfrey et al. [1] already demonstrated that erytrocyte magnesium levels in general 
correlated well with the serum magnesium level. They stressed the compounding 
influence of the erythrocyte age on the magnesium content. Younger cells have a 
higher magnesium content than older cells [16]. In magnesium deficiency the 
erytrocyte survival is reduced [8,10]. This should cause a raise in the average red cell 
magnesium content. Further studies on the distribution of Mg inside the erythrocytes, 
using NMR techniques, should therefore be initiated. The Mg content of the 
erythrocyte could be of value in monitoring of body magnesium content. 
Table 5. Mean and standard deviation of the measurements in 5 dogs at the end of 
the magnesium deficiency and when the se-Mg had become normal after 
supplementaion with MgO. 
n=5 
se-Mg 
mo-Mg \if!jmg prol. 
mo-Mg μ ^ π ^ DNA 
er-Mg 
mu-Mg 
bo-Mg 
end 
mean 
0.44 
1.04 
35 
111 
591 
1896 
(sd) 
(0.16) 
(0.19) 
(20) 
(20) 
(94) 
(358) 
restored se-Mg 
mean (sd) 
0.77 (0.07) 
1.26 (0.12) 
64 (33) 
136 (25) 
709 (84) 
1996 (398) 
Ρ 
<0.05 
<0.05 
ns 
<0.05 
<0.05 
ns 
Magnesium in se-Mg is expressed in mmol/l, mo-Mg: μg/mg protein and in Mg/mg DNA, er-Mg in 
μg/gr RBC dry weight, mu-Mg in μg/gr dry weight and bo-Mg in μg/gr dry weight. 
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Athough it is known that er-Mg is lowered in Mg deficiency [18], there is lack of 
sufficient information concerning the erthrocyte magnesium content changes during 
deficiency. In these experiments er-Mg was already lowered when the second biopsy 
was done (figure 1) in all dogs. In table 3 is shown that the er-Mg levels at the end of 
the deficiency period and after normalisation of the se-Mg (table 5), is lower than at 
the beginning of the experiment. 
The er-Mg content seems to be no simple reflection of se-Mg. Leinert et al. [12] 
showed se-Mg changes while er-Mg remained unchanged under acute alcohol load in 
men and despite elevated se-Mg amounts, normal er-Mg was found in haemodialysis 
patients [21]. Günther and Vormann [9] describe the impossibility of erythrocytes to 
take up magnesium in vitro when chicken-erythrocytes had been depleted by divalent 
cation ionophore A 23187, or in rat-erythrocytes depleted mildly with 2-deoxyglucose 
or by feeding a magnesium deficient diet. However the timescale between their and 
our experiment is quite different. Our data (fig. 3) suggest a positive correlation 
between er-Mg and bo-Mg with was significant in one dog only and nearly significant 
in 2 others. It is possible that the wide range in bo-Mg at the beginning of the 
experiment had an influence on this correlation. 
Table 6 . Median, minimal and maximal spearman correlation 
coefficients for compared data in all dogs (biopsies 1-6). 
Compared data 
se-Mg / mo-Mg μg/mg prot. 
/ mo-Mg μg/mg DNA 
/ mu-Mg 
/ bo-Mg 
mo-Mg μg/mg prot/ mu-Mg 
/ bo-Mg 
mo-Mg μΕΊι^ DNA / mu-Mg 
/ bo-Mg 
er-Mg / se-Mg 
/ mu-Mg 
/ bo-Mg 
/ mo-Mg μg/mg prot. 
„ / mo-Mg μg/mg DNA 
mu-Mg / bo-Mg 
г median 
0.31 
0.50 
0.21 
0.31 
0.03 
-0.03 
-0.31 
0.04 
0.81 
0.13 
0.30 
0.40 
0.22 
0.17 
r min 
-0.34 
-0.36 
-0.46 
-0.42 
-0.43 
-0.75 
-0.88 
-0.61 
0.09 
-0.37 
-0.43 
-0.79 
-0.29 
-0.14 
г max 
0.87 
0.70 
0.93 
0.84 
0.25 
0.54 
0.26 
0.60 
1.00 
0.49 
0.88 
0.89 
0.71 
0.77 
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Chapter 7 
EXPERIMENTAL MAGNESIUM DEPLETION IN THE DOG 
Relation between total and ultrafiltrable Mg in plasma 
and total and ionized Mg in erythrocytes 
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SUMMARY 
Experimental magnesium depletion was induced in dogs by a magnesium deficient 
diet. A clear divergence was observed between the lowering of plasma magnesium 
(nadir reached after one week) and the lowering of erythrocyte magnesium content 
(nadir reached after 3 weeks). As the magnesium stores became more depleted, the 
erythrocyte content progressively decreased while the lowered plasma level remained 
stable. The erythrocyte magnesium content in this study behaves as a good indication 
of body magnesium stores. The low permeability of the erythrocyte membrane for 
magnesium explains the gap between the nadir of magnesium in plasma and 
magnesium content of the erythrocyte. Ionized magnesium in the erythrocyte as 
measured by the 3 1 P NMR technique was clearly diminished after a period of 4 weeks 
magnesium deficient diet. 
INTRODUCTION 
In a previous study dealing with experimental Magnesium depletion in dogs, 
erythrocyte magnesium levels appeared to be a better reflection of the body 
magnesium stores than mononuclear cells. Due to the wide ranges, bone magnesium 
levels appeared to be inferior to erythrocyte magnesium content as an estimation of 
total body magnesium content [4]. As it is well known that red cells have a low 
magnesium permeability resulting in slow uptake and loss [2] it is important to know 
whether there will be a divergence in the rate of lowering of plasma magnesium and 
erythrocyte magnesium content after the introduction of a magnesium deficient diet. 
During this study not only plasma magnesium but also ultrafiltrable magnesium, as an 
approximate value of ionized magnesium, was measured together with ionized 
magnesium in red blood cells before the start and after 4 weeks of magnesium 
depletion. 
MATERIALS AND METHODS 
Ten, one year old inbread beagles were fed with a magnesium deficient diet as 
previously [4] during one month. The dogs were individually housed and got de-
ionised water at libitum. Before and during the experiment heparinised venous blood 
was drawn weekly at 9 a.m. after an overnight fast. Plasma magnesium was measured 
by atomic absorption spectrophotometry (Perkin Elmer 5000, Norwalk CT, USA). 
Ultrafiltrates were obtained after ultrafiltration with Amicon tubes (Amicon 
Corporation, Danvers,MA, USA) [1]. Erythrocyte total magnesium content was 
measured in lysed red blood cells as described previously [4], and expressed in μg/g 
red blood cells dry weight or mmol/1 cells. Hemoglobin level, hematocrit, number of 
erythrocytes, mean corpuscular volume, mean corpuscular hemoglobin and mean 
corpuscular hemoglobin concentration were measured with a Hl-jr (Technicon 
Instruments Corp. Tarrytown, NY, USA). The ionized erythrocyte magnesium level 
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Table I. Values of extra- and intracellular magnesium before and after 4 weeks of magnesium deprivation. 
ii=10 
day 0 
7 
14 
21 
28 
Plasma 
mmol/l 
mean 
(sd) 
0.75 
(0.07) 
0.42 
(0.10) 
0.38 
(0.09) 
0.36 
(0.11) 
0.34 
(0.10) 
Mg 
Ρ 
<0.01 
ns 
ns 
ns 
Ultra-
filtrable 
mmol/l 
mean 
(sd) 
0.48 
(0.08) 
0.26 
(0.07) 
0.24 
(0.07) 
0.22 
(0.08) 
0.24 
(0.08) 
Mg 
Ρ 
<0.01 
ns 
ns 
ns 
Erythrocyte Mg 
ßllgRBC 
mean 
(sd) 
171 
(И) 
143 
(19) 
112 
(21) 
100 
(22) 
95 
(25) 
mmol/l 
Ρ 
<0.01 
<0.01 
<0.02 
ns 
mean 
(sd) 
2.89 
(0.21) 
2.44 
(0.35) 
1.89 
(0.33) 
1.71 
(0.39) 
1.62 
(0.45) 
Ρ 
<0.01 
<0.01 
<0.02 
ns 
ve 
ы 
was measured by means of 3 1 P NMR as described by Gupta et al [8]. Briefly, ten 
milliliters of freshly drawn heparimzed venous blood was centrifuged and glucose was 
added to the plasma to a concentration of 10 mmol/1. The plasma was then mixed 
with the red blood cells and incubated at room temperature for 10 minutes. The 
blood was centrifuged and an eryhtrocyte-suspension obtained with a hematocrit of к 
90 %. Complete oxygenation was ensured with 95% oxygen and 5% C 0 2 in a 
tonometer (Instrumentation Laboratory, Milano, Italy). The wet and dry weights of 
exactly 0.1 milliliter erythrocyte suspension, with known hematocrit, were measured 
with a microbalance and waterfraction, dry weight and density of the red blood cells 
were calculated. The ATP and 2,3-DPG levels in the red blood cells were determined 
using Sigma diagnostic kits (Sigma Chemical Co, St Louis, USA). 
The sample was transferred into a 10 mm outer diameter glass NMR tube with a 4 
mm outer diameter coaxial insert containing D 2 0 for deuterium lock. 
""P NMR spectra were recorded at 81 MHz and 37° С on a Bruker WM 200 
spectrometer (Bruker, Karlsruhe, FRG) operating in the Fourier transform mode. 
Pulses of 55° in combination with gated proton decoupling were applied with a 
repetion time of 0.78 seconds; the samples were spun at 10 Hz during the entire 
recording. 
The calculations of the concentrations of complexes of ATP and 2,3-DPG with Mg2+ 
and /or hemoglobin were done essentially according to Gupta et al. [8] and expressed 
in mmol/liter cell water. The free fraction of ATP not complexed to magnesium (φ) is 
calculated from the NMR spectrum and the equations listed in Gupta's paper. 
[ATP]b 
Φ = 
[ATP]T 
Where ATPF is ATP free and ATPT is ATP total. 
In wich ¿""„β is the measured resonance position of the ß-resonance of ATP with 
respect to the α-resonance, which has a nearly constant position. 
[Mg^], = K d ^ ™ [(1/Φ) -1] 
Where KdM g A T P is the dissociation constant for the reaction 
MgATP » Mg2+ + ATP 
KdMgA-n· = 3 8 χ 1 0 5 M a t 3 r c a n d p H 7 2 ßj 
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Statistical methods 
Spearman's rank correlation coefficients (r) were used to detect relationships between 
different variables and Wilcoxon's signed rank test to detect differences between 
variables determined on different data. Results were considered to be significant when 
ρ <0.05. 
mmol /I 
l O - i 
ι 1 1 1 1 
ug/g RBC dry weight 
•—erythrocyte total Mg 
τ 1 1 1 г 
0 1 2 3 4 
Weeks of deficiency 
Figure 1. Plasma total, ultrafiltrable and eiythrocytc magnesium before and during 4 weeks of 
magnesium deficient diel show considerable difference in rapidity of decrease between cxlra-and 
intracellular magnesium. 
RESULTS 
Results of plasma-, ultrafiltrable- and total erythrocyte magnesium determinations at 
day 0, 7, 14, 21 and 28 are shown in table 1. Plasma- and ultrafiltrable magnesium 
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decreased during the first week of magnesium deficient diet (p <0.01) and remained 
at a constant level during the rest of the experimental period (fig. 1 upper panel and 
table 1). Erythrocyte magnesium content, however behaved differently. The lowest 
level was obtained after three weeks (fig. 1 lower panel). There was a clear delay in 
time when the lowest eryhtrocyte content was compared with the lowest plasma and 
ultrafiltrable magnesium (fig. 1). 
/VwW^ 
2,3-DPG 
daß = 694.57 Hz 
y-ATP a-ATP ß-ATP 
VYYUlAvv-vAiy^Aj W^w^WV Чм—W* ÍV^V*V* лЛ\ 
•AAt^H 
2,3-DPG 
daß = 745.19 Hz 
ß-ATP y-ATP a-ATP 
Figure 2. 31P NMR spectra of oxygenated erythrocytes from dog 41 before (upper panel) and after 
(lower panel) 4 weeks of magnesium deprevation shows a shift in the ß-ATP peak due to decreased 
intracellular ionized magnesium content. 
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Figure 2 shows the NMR-spectrum of the erythrocytes before and after 4 weeks of 
magnesium deficient diet. In contrast to the stable position of the ot-ATP peak, there 
is a clear shift in the ß-ATP peak position after four weeks of magnesium deficient 
diet, reflecting a difference in intracellular ionized magnesium content. 
The ATP content of the erythrocytes was decreased after 4 weeks of deficient diet 
(Table 2). This presumably is due to the fact that ionized magnesium is an important 
cofactor for many glycolytic enzymes such as phosphofructokinase [6]. In intact human 
red cells the intracellular content of ATP decreases as the magnesium content of the 
cell was reduced [3]. 
In figure 3 the apparent relation is shown between ionized intracellular magnesium 
content of the erythrocytes and plasma ultrafiltrable magnesium. Statistical 
calculations, however, did not show a significant correlation separately on the data 
before (r = 0.47, ρ = 0.07) and after 4 weeks of deficient diet (r = 0.24, ρ = 0.26). 
This is possibly due to the limited numbers of data available. 
Table 2. Relevant cellular compounds and characteristics before and after 4 weeks of 
magnesium deprivation. 
n=10 
Φ 
[Mg2*], 
ATP 
2,3-DPG 
IH 2O 
dry weight 
density 
MCV 
MCH 
MCHC 
before 
mean 
0.132 
0.31 
1.12 
10.36 
0.724 
0.407 
1.131 
69 
1.47 
21.2 
(sd) 
(0.012) 
(0.03) 
(0.13) 
(0.29) 
(0.009) 
(0.010) 
(0.014) 
(3) 
(0.03) 
(0.8) 
after 4 weeks 
mean 
0.259 
0.15 
0.74 
10.26 
0.718 
0.411 
1.178 
70 
1.51 
21.6 
(sd) 
(0.071) 
(0.06) 
(0.15) 
(0.85) 
(0.014) 
(0.015) 
(0.014) 
(2) 
(0.06) 
(0.9) 
Ρ 
<0.01 
<0.01 
<0.01 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
(Mg2"1"],, ATP, 2,3-DPG in mmolA cell water, fl^O, dry weight, density in gram per ml red blood cells, 
MCV fl, MCH fmoW, MCHC ттоШ. 
DISCUSSION 
Total plasma- or serum magnesium concentrations may not adequately reflect body 
magnesium stores. It was our aim to establish the magnesium content of the red blood 
cells as an estimation of these body stores. In contrast to the lowering of plasma 
magnesium, the nadir of red blood cell magnesium was only obtained after 3 weeks of 
magnesium deprevation. This divergence was also observed in an earlier study, when 
at the end of the period of magnesium deficiency, serum magnesium was restored 
after supplementation with MgO [4]. After one week of supplementation the serum 
magnesium was normal but the erythrocyte content of magnesium was still decreased. 
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This former study demonstrates that the degree of deficiency in the erythrocytes 
depends on the duration of the period of deficient diet and probably (no balance 
studies were performed) on the amount of body magnesium loss. A similar study was 
recently performed in normal human volunteers by Ryzen et al. [9] In four normal 
subjects they observed a progressive fall in both serum and red blood cell magnesium 
during magnesium depletion, with a concomitant rise in retention of parenterally 
administered magnesium. Only data before and after two and three weeks of 
magnesium deficiency were available. As was demonstrated for the dogs (vide supra) 
after 4 weeks of magnesium deprivation, in humans Ryzen et al. [9] observed a 
decrease of ionized free magnesium m red blood cells, measured with the 3 1P NMR 
technique as we did. 
[Mg2 j ι (mmol/l cell water) — 
• before Mg-deficiency 
0 3-| о after Mg-deficiency 
Ο Ζ ­
ΟΙ 
• · · · 
о 
о 
о 
о 
о 
1 1 1 1 1 Г 
01 0 2 03 Оі, 0 5 0 6 
uf-Mg (mmol/() 
Figure 3 Ionized intracellular magnesium content and plasma ultra filtrable magnesium show an 
apparent relation 
It is striking that the magnesium content of the erythrocytes progressively decreased 
although these erythrocytes are surrounded by a constant ultrafiltrable and 
presumably ionized magnesium. The red cell magnesium permeability appears to be 
very low. Ginsberg et al. [5] could detect no significant uptake of ^Mg by human red 
blood cells during an incubation period of 24 hours at 370C. Flatman [2] reported that 
storage of erythrocytes at 40C in media containing no magnesium for up to one week 
leads to little change in red cell magnesium content. Even during a period of 
magnesium deficiency the red cell ionized magnesium concentration remained below 
the electrochemical equilibrium This means, that an active magnesium extrusion is 
still present. As magnesium efflux studies in magnesium loaded red blood cells have 
demonstrated, this efflux depends for 10% on extracellular sodium and for 90% on 
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net chloride efflux for charge compensation [7]. A lowering of ionized magnesium 
outside the erythrocyte, lowers the intracellular concentration of ionized magnesium of 
the erythrocytes in such a system. The exact mechanism of magnesium transport in 
human red blood cells is still not definitely established [2]. 
We can conclude that in dogs with experimental magnesium deficiency, erythrocyte 
magnesium levels are a better reflection of the body magnesium status than plasma 
magnesium levels. As the magnesium stores become more depleted during the course 
of the magnesium deficient diet, the erythrocyte magnesium content progressively 
decreases while plasma magnesium content reaches its nadir after one week of 
depletion. 
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SUMMARY 
Intracellular ionized magnesium concentrations [Mg2"1"], were estimated in erythrocytes 
by 31Phosphorous Nuclear Magnetic Resonance (31P NMR) and zeropoint titration 
(ZPT) in 14 controls and 7 patients with renal magnesium loss. Total and ultrafiltrable 
magnesium concentrations in plasma and total magnesium concentrations in 
erythrocytes were also determined. The mean intracellular ionized magnesium 
concentration in controls measured by 21Р NMR was 0.20 ± 0.03 mmol/L cell water, 
in contrast to a value of 0.55 ± 0.12 mmol/L cell water obtained by zeropoint 
titration. Total red blood cell magnesium content measured with the lysate method 
was 0.63 mmol/L cell water higher than estimated by 3 1 P NMR probably because not 
all magnesium complexes are fully visible by the NMR technique. We found a positive 
correlation between plasma ultrafiltrable magnesium and [Mg2"1"], irrespective of the 
[Mg2+]1-assay used. [Mg2"1"], measured with 3 1P NMR also correlated with [Mg2"1"], 
determined by zeropoint titration. 
Washing erythrocytes before the zeropoint titration procedure, decreased the ATP 
content, which could partially be restored by incubating with inosine. The cell water 
fraction was also lower after the washing procedure. It is concluded that the decrease 
in cell water and ATP levels in the erythrocytes overestimates [Mg2"1-], when measured 
with zeropoint titration. Evaluation of influences of dissociation constants used in 
calculating the ionized and total magnesium concentrations from the NMR results, led 
us to conclude that a variation in every dissociation constant markedly influences the 
calculated results of [Mg2"1"],. Although absolute values for [Mg2"1"], differ with the assay 
used, significantly lower values for [Mg2*], were found in patients with isolated renal 
magnesium loss by both methods. 
INTRODUCTION 
Magnesium is the second most abundant intracellular cation. It is present in bound 
[MgB] and free [Mg2+] form. Several methods for the measurement of total cellular 
magnesium content have been described, but intracellular free [Mg2"1"], is physiological 
relevant and is therefore of special interest. A wide range of [Mg2"1"], has been 
reported, by several investigators [1] for a number of cell types, using different 
techniques. A threefold rise in [Mg2"1"], has been reported in deoxygenated red blood 
cells while total intracellular magnesium content did not change [2]. On the other 
hand, in hepatocytes [Mg2*], appeared to be very sensitive to variations in total 
magnesium, hence small increases or decreases in total magnesium resulted in large 
variations of [Mg2+], [3]. 
Differences were also reported between [Mg2"1"], when measured with 3 1P NMR 
spectroscopy as developed by Gupta et al. [2] or by zeropoint titration (ZPT) as 
described by Flatman and Lew [4]. We are not aware, however, of a study in which 
both techniques are were used simultaneously. 
The aim of the present study is to compare 3 1P NMR being an "indirect" method with 
the "direct" zeropoint titration method, to measure [Mg2+], in human erythrocytes. We 
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applied both methods to oxygenated erythrocytes from healthy controls and from 
patients with isolated renal magnesium loss [5]. 
METHODS 
Plasma magnesium was measured by atomic absorption spectrophotometry (Perkin 
Elmer 5000, Norwalk CT, USA). Ultrafiltrates were obtained after ultrafiltration with 
Amicon tubes (Amicon Corporation, Danvers, MA, USA) [6]. Erythrocyte total 
magnesium content was measured in lysed red blood cells as described previously [7], 
and expressed in mmol/L cell water. Hemoglobin level, hematocrit, number of 
erythrocytes, mean corpuscular volume, mean corpuscular hemoglobin and mean 
corpuscular hemoglobin concentration were measured with a Hl-jr (Technicon 
Instruments Corp. Tarrytown, NY, USA). 
WDPG 
ίαβ 709 00 Hz 
Г-АТР « ATP ß ATP 
Λ , Í * fffftf^mktH'f'î tfVvivì*! f·* 
2,3 DPG 
tap 723 30 Hz 
11 
VNftA' 
P-ATP 
ij \і{*Л>*{кг*^ М , дм Ψ^ψΛψ^ У м 
Figure 1. 3 1 Р NMR spectra of a control person (upper part) and a renal Mg loss patient (lower panel) 
show differences in the D-ATP peak position and бай. The values for [Mg2+]1 were 0.20 and 0.14 
mmol/L cell water respectively. 
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3 1 P NMR 
Ten mL of freshly drawn heparinized venous blood was centrifuged and 10 mmol 
glucose was added to the plasma. The plasma was mixed with the red blood cells and 
incubated for 10 min at 20° C. The blood was centrifuged and an erythrocyte-
suspension with a hematocrit of и 90 % was obtained. Complete oxygenation was 
ensured with 95% oxygen and 5% C 0 2 in a tonometer (Intrumentation Laboratory, 
Milano, Italy). The sample was transferred into a 10 mm outer diameter glass NMR 
tube with a 4 mm outer diameter coaxial insert containing D20 for deuterium lock. 
3 1P NMR spectra were recorded at 81 MHz and 37° С on a Bruker WM 200 
spectrometer (Bruker, Karlruhe, FRG) operating in the Fourier transform mode. 
Pulses of 55° in combination with gated proton decoupling were applied with a 
repetition time of 0.78 seconds; the samples were spun at 10 Hz during the entire 
recording. 
The calculations of the concentrations of ATP and 2,3-DPG complexed to Mg2+ 
and/or hemoglobin were done essentially according to Gupta et al. [2] and expressed 
in mmol/L cell water. The free fraction of ATP not complexed to magnesium (Ф) is 
calculated from the NMR spectrum by means of the equations listed in Gupta's paper 
[2], solved with the aid of Newton's iteration method using a program for IBM 
compatible computers. 
[ATP]F + [HbATP] 
* = (1) 
[ATP]T 
Where ATPF is ATP free and ATPT is ATP total. 
( i«V 5 " ^ ) 
Φ (2) 
In which ¿""„β is the measured resonance position of the ß-resonance of ATP with 
respect to the α-resonance, which has a nearly constant position. 
[ M g 2 ! = K d ^ 1 7 [(1/Φ) -1] (3) 
Where KdMeA T P is the dissociation constant for MgATP. KdMeATP = 3.8 χ 10·5Μ at 
370C and pH 7.2 [2]. 
The total magnesium concentrations are calculated as the sums of the concentrations 
of all magnesium containing complexes and free magnesium, neglecting the possible 
amount of magnesium complexed to other red cell constituents. 
ATP and 2,3-DPG levels in the red blood cells were determined using comercial kits 
(Sigma Chemical Co, St Louis). 
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Zeropoint titration 
Ten mL of freshly drawn heparinized venous blood was centrifuged. The plasma was 
removed and the red blood cells were washed 3 times in medium I (75 mmol/L KCl, 
75 mmol/L NaCl, 10 mmol/L Tris-Cl, pH 7.4, 37° C) containing 0.1 mmol/L EGTA to 
chelate contaminant calcium and extracellular magnesium [4]. The cells were then 
washed twice in medium I containing 10 ¿xmol/L EGTA and oxygenated with 95% 
oxygen and 5% COj in a tonometer. Packed cells were then added to the incubation 
medium (medium I with 10μιηο1/ί EGTA and 10 mmol/L inosine) containing 
different concentrations of magnesium (hematocrit ±15%). After 10 min incubation 
at 37° С under constant stirring in plastic vials, samples were taken for the 
measurement of the initial magnesium content of the cells. At t=0 ionophore A23187 
was added to reach a concentration of 10 μιηοΐ/ί. At t=10 and t=20 min 0.5 mL 
samples were taken to measure the magnesium content of the cells. Samples were 
ejected into an Eppendorf microcentrifuge tube containing 0.8 mL icecold inactivation 
medium I (with 10 дтоІ/L EGTA) and 0.4 mL di-n-buthylphtalate (density 1.042 
g/ml) and immediately centrifuged at 8000 χ g for 1 min. The medium and oil were 
removed, the tube carefully cleaned with a bevel cut disposable "sample cells and 
chamber cleaner" (Advanced Instruments, Needham Heights, Massachusetts, USA), 
the cell-pellet lysed in 400 ¿iL distilled water and frozen at -20° С until assay. 
At t=10 min besides a sample for the magnesium content of the red blood cells, we 
took also twice 0.1 mL for measuring the hematocrit, twice 0.1 mL for the water 
fraction (f,,) and density, and twice 0.4 ml for the chloride distribution ratio (r). 
Water fraction^), dry weight(dr.wt) and density(dens.) 
The wet and dry weight of 0.1 mL erythrocyte suspension with known hematocrit were 
measured and the water fraction and density of the red blood cells were calculated. 
No correction for entrapped water was necessary because the Hl-Jr calculates the 
hematocrit as the number of red blood cells multiplied by their Mean Corpuscular 
Volume. 
Chloride distribution ratio(r) 
To an Eppendorf tube containing 0.4 mL cell suspension 50 μΐ. tracer ^Cl (5 μΟΊπί; 
Amersham International pic, Amersham, England) was added and incubated at 37° С 
for 10 min. Then di-n-buthylphtalate (0.4 mL) was added and the sample spun at 8000 
χ g for 5 min. A 100 ßL sample was taken from the supernatant, and the rest was 
carefully and completely removed before 0.150 mL 5% TCA was added to the cell 
pellet. -^Cl activities in the supernatant and cell pellet were determined in duplo by 
liquid scintillation counting (Searle Mark III liquid scintillation counter, Searle 
Analytic Inc., Des Plaines, 111., USA). 
r = [Cl-]0/[Cl]1, (4) 
were [СГ]0 and [СГ], are the ^Cl activities in 100 μ ι of supernatant and cell water 
respectively. 
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Ionized magnesium concentration 
The concentration of ionized magnesium in the medium at equilibrium ([Mg2+]0) was 
extrapolated from the initial and final magnesium concentrations of the red blood 
cells and the magnesium concentrations in the corresponding medium. 
[Mg2+]1 was then calculated according to: 
[ M g 2 ! = τ2 [Mg2+]0 (5) 
Statistics 
Spearman's rank correlation coefficients were used to detect a possible relation 
between variables and the signed rank test was taken to test for significant differences 
between different variables. Results were considered to be significant when ρ <0.05. 
Table 1. Results ( mean ± 1 sd ) of the different variables in controls and patients 
with renal magnesium loss. 
η 
se-Mg mmol/L 
uf-Mg mmol/L 
Lysate: 
[MgT], mmol/L 
cell w. 
3 1
Ρ NMR 
[MgTJ, mmol/L 
cell w. 
[Mg 2 + ] i mmol/L 
cell w. 
ZeroPoint Titraiion 
η 
[Mg 2 + ] i mmol/L 
cell w. 
Controls 
14 
0.83 
0.57 
3.00 
2.37 
0.20 
11 
0.55 
(0.04) 
(0.04) 
(0.38) 
(0.22) 
(0.03) 
(0.12) 
Patients 
renal 
7 
0.46 
0.33 
2.77 
1.94 
0.13 
6 
0.36 
М| 
with 
; loss 
(0.11) 
(0.09) 
(0.14) 
(0.17) 
(0.02) 
(0.03) 
Ρ 
<0.01 
<0.01 
ns 
<0.01 
<0.01 
<0.01 
RESULTS 
In table 1 the relevant data obtained from the blood of controls and patients with 
renal magnesium loss are listed. In comparison to controls, patients have significantly 
lower values for plasma, ultrafiltrable and [Mg2+]1, measured either with NMR and 
ZPT, than controls. In patients with renal magnesium loss Φ is higher than in 
controls; 0.265 respectively 0.193, so relatively more magnesium is complexed with 
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ATP. No differences between the two groups were found for ATP, DPG, water 
fraction, chloride distribution ratio and density. The total erythrocyte magnesium 
contents measured in the lysate by atomic absorption spectrometry were not lower in 
patients compared with controls. However, when the total erythrocyte magnesium 
content was measured by 31P NMR, the patients had significant lower values than the 
controls. 
Figure 1 shows the 31P NMR spectra of one control and one patient with renal 
magnesium loss. A difference in the ß-ATP peak position is noticed, resulting in daß 
being 709.00 Hz in the control and 723.30 Hz in the patient with renal magnesium 
loss, whereas [Mg2+]1 was 0.20 and 0.14 mmol/L cell water respectively. 
In figure 2 the relation between plasma ultrafiltrable magnesium and NMR-fMg2"1"], 
(upper panel) and ZPT-[Mg2+]1 (lower panel) is shown. Plasma ultrafiltable Mg is 
positive correlated with NMR-tMg^], (r = 0.71, ρ <0.01) as well as ZPT-fMg2"1"], (r = 
0.61 and ρ <0.01). 
NMR-|Mg2«|i mmol/l cell water 
0 2 
0 1 
• Controla 
• Renal Mg loss 
0 0 2 
ZPT-|Mg2·]! mmol/l cell water 
ι 
* Controls 
• Renal Mg loss 
О б -
ОД 
• 
• · t · 
• 
w 
0 4 0 6 
ultrafiltrable Mg m mol/ 
0 2 0 4 0 6 
ultrafiltrable Mg mmol/l 
Figure 2. Plasma ultrafiltrable magnesium and NMR^Mg2"1'], show a good correlation ( r = 0.71, ρ 
<0.01 )( upper panel ), whereas ZPT-fMg2"1"], and plasma ultrafiltrable Mg have also a good 
correlation ( r = 0.61, ρ <0.01 )( lower panel ). 
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Total erythrocyte magnesium concentration ([MgT],) shows a significant correlation 
with [Mg2*], obtained with both methods (figure 3). [MgT], correlates (r = 0.63, ρ 
<0.01) with NMR-[Mg2+], as well as with ZPT-[Mg2+], (r = 0.66, ρ <0.01). In twelve 
out of fourteen controls NMR-[Mg2+], ( = 0.20 mmol/L cell water) is nearly constant 
while total magnesium varies between ± 2.5 and 3.7 mmol/L cell water (figure 3a). 
When we compare the results obtained by NMR and ZPT we observe that NMR-
[Mg2*], remains nearly constant for a wide range of ZPT-[Mg2+]l values (figure 4) in 
controls and at a lower level also in samples taken from patients with renal 
magnesium loss. NMR-[Mg2+], and ZP^Mg2"1"], correlate ( r = 0.58, ρ <0.01) when 
the samples of controls and patients are taken together. 
In order to find an explanation for the considerable difference in [Mg2"1"], values 
described by the two methods, we investigated the differences in ATP, DPG, the 
water fraction and dry weight before and after the washing procedure in the ZPT 
experiments. Total erythrocyte magnesium and DPG (not shown) did not change, but 
ATP decreased considerably during washing and was partly restored during incubation 
with inosine prior to the addition of the ionophore. The final decrease in ATP 
concentration ranged between 6 to 15%, compared to the situation before washing. 
Table 2. Water fraction and dry weight before (I) and after (II) washing and then 
incubation in buffer (III) containing different magnesium concentrations. 
dry weight 
I before washing 8 0.722 0.406 
(0.029) (0.020) 
II after washing 7 0.673 <0.02 0.465 ns 
(0.042) (0.036) 
incubation in 
III Mg 0.3 mmol/L 8 0.666 ns 0.4β7 <0.05 
(0.065) (0.032) 
Mg 0.1 mmol/L 5 0.655 ns 0.505 ns 
(0.088) (0.014) 
The water fraction and dry weight were measured before, immediately after washing 
and after 10 min incubation with 0.1 or 0.3 mmol/L magnesium and inosine 
(10mmol/L) in the presence of the ionophore. The water fraction decreased after the 
washing and incubation procedure (table 2). Dry weight was the same before and 
after the ZPT-washing procedure. 
To test the influence of dissociation constants on the results, obtained from the 3 1P 
shifts by means of in the NMR technique, a value was drawn at random for every 
dissociation constant out of all values between the mean ± 2 sd. Then NMR-tMg2*], 
and NMR-fMgT], were calculated. This procedure was repeated 1000 times for every 
control and patient. From this approach it followed that NMR-[Mg2+], is 0.19 ± 0.08 
in controls and 0.13 ± 0.04 in renal magnesium loss patients, whereas NMR-lMgT], is 
2.36 ± 0.25 and 1.92 ± 0.17 respectively. 
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DISCUSSION 
For the determination of [Mg2+]¡ in erythrocytes no "golden standard" is available and 
the two methods, 31P NMR and zeropoint titration, lead to different [Mg24"], values. 
31P NMR 
The mean [MgT]i, the result of the sum of the concentrations of magnesium 
containing complexes and the free magnesium concentration, was approximately 0.6 
mmol/L cell water lower when determined by the NMR than measured via the lysate 
method. 
[MgT]i mmol/l cell water 
• Controle 
3 .5 ' 
2 5 -
T
 Renal Mg loas · 
2 — 
O l 0 15 
О 2 0.25 0.3 
NMR-[Mg2+]i mmol/1 cell water 
[MgTlr mmol/1 cell water 
I 5 i · Controls 
ι
 T
 Renal Mg loss · 
2 . 5 -
2 L -
0.3 0.4 
. I 
0.5 0 6 0.7 0.8 
ZPT-[Mg2+]i mmol/1 cell water 
Figure 3. Total erythrocyte magnesium content and [Mg2+]; are significantly correlated, although 
(Mg2+]i shows little variations while [MgTJj varies from 2.5 to 3.7 mmol/L cell water. 
It is suggested that this difference of approximately 25% might be caused by binding 
of magnesium to cell membranes [8]. In our calculations of the [MgT]i from the NMR 
data all possible complexes considered by Gupta [2] were accounted for. This includes 
the hemoglobin ATP complex (Hb02[ATP]). The dissociation constant of the latter 
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complex may vary considerably, i.e. Kd = 3.43 ± 0.85mmol [2]. In addition, not all 
ATP may be available for binding to magnesium, a situation not recognized in the 
calculations. After critical evaluation [9,10] of the dissociation constant for Mg-
ATP[2], it was concluded that KdMeATP, as used in this paper, is correct. Recently, 
Petersen et al. [11] stated that NMR-IMg2-1"], measurements derived solely from the 
separation of the o- and ß-ATP peaks do not lead to 'a true measurement of 
intracellular free magnesium levels and that the concentrations of the magnesium 
ligands ATP and 2,3-DPG must be taken into account [11]. 
We found a considerable range of NMR^Mg2"1^],, but NMR-fMgTJj showed less 
variation. The observed spreading in NMR-fMg2"^], is not caused by variations in 
oxygenation and pH [11]. Full oxygenation (Sa02 > 98%) was achieved and the pH of 
the blood sample was 7.38 ± 0.01. 
NMR-[Mg2+]i mmol/l cell water , 
• Controls 
T
 Renal Mg loss 
ι ι 
0.2 0.4 0.6 0.8 
ZPT-[Mg2+]i mmol/l cell water 
Figure 4. 3 1 P NMR and Zeropoint titration measurement of [Mg2"1"], show a significant correlation; 
r=0.58> p<0.02. 
Zero point titration 
Values of [Mg2+] i obtained with zeropoint titration varied from 0.4 mmol/L cell 
water[4] to 0.75 mmol/L cells [12] corresponding to 1.13 mmol/L cell water, assuming 
a cell water fraction of 0.66. However in Wehlings study [Mg2+]j was estimated from 
the amount of magnesium released from magnesium loaded erythrocytes [12]. 
In our study water fraction and chloride distribution ratio were similar to the values 
reported by Flatman et al. [4] but mean ZPT-[Mg2+]i was ± 0.15 mmol/L cell water 
higher in our study. Most likely, the limited number of donors (n=2) investigated by 
Flatman et al. may explain this difference. 
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Differences between Ρ NMR and Zero point titration 
Although our results derived with both methods are close to the reported normal 
values, the two techniques yield a considerable mean difference of 0.35 mmol/L cell 
water in [Mg2*], in controls. Bock et al. [13] suggested that the washing step used 
before application of the null point titration procedure might alter [Mg2"1"], and 
reported an increase of [Mg2*], after washing stored red blood cells in buffer. The 
decrease in erythrocyte ATP found after washing red blood cells for zero point 
titration and the partly restoration of the ATP level during the following incubation in 
a magnesium-inosine-ionophore containing buffer might be a possible source of the 
difference in [Mg2+]j. Flatman and Lew [4] pointed to a nearly ten-fold increase of 
[Mg2*], when the ATP level was lowered from normal ( 1.66 ) to 0.2 mmol/L cell 
water. So a final decrease in the intracellular ATP level of 6 - 15% that we found in 
erythrocytes used for null point titration might be, at least partly, responsible for the 
difference in [Mg2-1^ found between 3 , P NMR and zeropoint titration. Further 
investigations are necessary to prove this suggestion. 
The changes in water fraction and dry weight which observed to occur during the 
washing procedure and the further changes in dry weight during the null point 
titration in a medium containing higher magnesium concentrations, indicate changes in 
cell volume and results in an increase of [Mg2*]) measured with ZPT of ± 10%. 
Ultrafiltrable magnesium 
In controls the ionized magnesium concentration in the red blood cell is normally 
below the electrochemical equilibrium concentration [14]. The same applies to our 
patients with isolated renal magnesium loss. An active magnesium extrusion 
mechanism is present which was shown to be dependent on extracellular sodium for 
10% and on net chloride efflux for charge compensation for 90% [15]. Lower 
extracellular magnesium concentrations lead to lower intracellular ionized magnesium 
concentrations in magnesium loaded red blood cells [15]. It is striking that the 
intracellular ionized magnesium concentrations as measured by zeropoint titration 
approaches the value of ultrafiltrable Mg is plasma. However, the exact mechanism of 
magnesium transport and homeostasis in human erythrocytes is not jet established 
[14]. 
The zeropoint titration method should be prefered because it is a direct method. The 
interpretation of the 3 1P NMR results is dependent on the available K-values; 
deviations in the equilibrium constants or in the availability of the substrate may result 
in incorrect values of the calculated magnesium concentration. Although the both 
methods lead to different results, significant differences between controls and patients 
with renal magnesium loss are obtained independent of the method used. 
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SUMMARY 
Based on the serum magnesium level, the urinary excretion of calcium, the 
concentrating ability and the glomerular filtration rate it is possible to make a 
distinction between Bartter's syndrome, a defect localized in the medullary part the 
thick ascending limb of the loop of Henle and Gitelman's syndrome, a defect localized 
in the distal nephron after the medullary part of the ascending limb of the loop of 
Henle. A few patients, however, cannot be classified. From the fifteen investigated 
patients seven had a lowered serum magnesium level. From this seven five had also a 
slightly reduced content of magnesium in the erythrocyte. The magnesium content of 
the mononuclear cells expressed as μg/protein or μg/DNA was normal in all patients. 
A pronounced magnesium deficiency was apparently not present in these group of 
patients. 
INTRODUCTION 
Bartter's syndrome is characterized by chronic hypokalemia due to renal potassium 
wasting accompanied by mild to moderate alkalosis and hypochloremia. Defective 
chloride transport in the thick ascending limb of loop of Henle is considered to be the 
primary cause of Bartter's syndrome. The increased prostaglandin production and 
hyperreninemia are thought to be secondary as it is also observed in pseudo-Bartter's 
syndrome (e.g. habitual vomiting). A defect in the tubular reabsorption of magnesium 
associated with renal potassium loss (Gitelman's syndrome) can be distinguished from 
Bartter's syndrome by the milder symptoms, a normal diluting ability and relatively 
intact concentrating ability according to Gill et al. [1]. As described further on in this 
paper new criteria will be formulated for both syndromes. In a study of an infant with 
the severe type of Bartter's syndrome Mach et al. [2] observed a lowered content of 
muscle magnesium although the serum magnesium level was normal. After the 
introduction of oral magnesium therapy, there was marked improvement in muscle 
strength; the intramuscular concentration of magnesium increased to a normal level. 
In four adult patients with a decreased serum concentration of potassium and 
magnesium, a normal amount of magnesium was observed in muscle tissue [3]. In 
thirteen children and two adults with Bartter/Gitelman's syndrome, serum magnesium 
and urinary magnesium excretion were determined together with the intracellular 
content of magnesium in the erythrocytes and mononuclear cells. 
Magnesium depletion appeared to be absent in mononuclear cells in both syndromes. 
Five out of the seven patients with a lowered serum magnesium had also a lowered 
magnesium content of the erythrocytes. Serum magnesium and the magnesium 
content of the erythrocytes were significantly correlated. 
PATIENTS AND METHODS 
In table I the most relevant blood (plasma, serum) values are presented of the 
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Figure 1. Plasma renin activity and urinary excretion of prostaglandin E^ and PGF^ 
in all patients according to age. 
X indicates clearance of creatinine < 80 ml/min.1.73 m2. 
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Table 1. Relevant blood values in the fifteen investigated patients. 
Initials Age at the Na К Cl HCOj pH 
time of 
investigation: 
yean mmoiyi 
1. B.B. 
2. B.R. 
3. A.T. 
4. G.M. 
5. N.J. 
6. MX. 
7. A.S. 
8. Y.C. 
9. A.B. 
10. J.v.d.R. 
11. C.v.d.H. 
12. Y.v.d.H 
13. M.V. 
14. S.V. 
15. v.d.H-H. 
12/12 
14/12 
9 4/12 
17 4/12 
14/12 
7 8/12 
2 8/12 
3 weeks 
4 7/12 
7 4/12 
11 5/12 
30 
11 4/12 
9 8/12 
31 
136 
138 
141 
138 
138 
138 
137 
118 
141 
145 
138 
138 
141 
143 
139 
2.7 
3,4 
2,7 
3,1 
3,0 
3,6 
3,5 
2,7 
3,8 
2,3 
2,6 
2.5 
2,9 
2,7 
2,1 
100 
81 
99 
-
102 
105 
100 
67 
101 
103 
93 
94 
96 
97 
95 
26,0 
33,7 
28,5 
27,5 
23,9 
23,6 
26,6 
29,9 
23,6 
26,2 
31,3 
27.5 
29,5 
26,5 
27,7 
7,39 
7,50 
7,47 
7,38 
7,46 
7,43 
7,39 
7,47 
7,44 
7,39 
7,42 
7.46 
7,38 
7,42 
7,51 
BE pCOj Mg Ca plasma renin classification 
activity 
mmol/l kPa mmol/l ng/mLhour 
0,9 
18,5 
5,3 
1.8 
11,2 
0,2 
1,5 
6,3 
-1,0 
1,5 
5,9 
4.4 
3,4 
2,4 
5,9 
6,0 
5,7 
5 3 
6,4 
4,7 
4,9 
6,1 
5,6 
4,8 
5,7 
6,7 
5.1 
6,9 
5,6 
4,7 
1,00 
0,83 
0,91 
0,89 
1,03 
0,77 
0,78 
0,86 
0,88 
0,69 
0,62 
0.54 
0,58 
0,68 
0,58 
2,63 
2,81 
2,50 
2,52 
236 
2,37 
2,44 
2,30 
2,55 
239 
2,52 
2.76 
2,40 
2,53 
2,59 
91,9 
48,3 
19,0 
33,0 
136,0 
9,1 
23,0 
900 
40,7 
14,6 
31,8 
32,2 
9,5 
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11,8 
Banter 
? 
Banter 
Banter 
Banter 
? 
? 
Bartier 
Banter 
Gitelman 
Gitelman 
Gitelman 
Gitelman 
Gitelman 
Gitelman 
Patients 11-12 and 13-14 are siblings. 
Table 2. Urinary excretion of prostaglandins, magnesium and calcium in all patients. 
Initials Prostaglandin excretion Mg and Ca excretion 
PGEj PGF^ 6-Kelo-PGF1(I TXB2 Mg Ca 
ng/day.1,73 m2 SA mg/kg day 
1. B.B. 
2. B.R. 
3. A.T. 
4. G.M. 
5. N.J. 
6. M.L. 
7. A.S. 
8. Y.C 
9. A.B. 
10. J.v.d.R. 
11. Cv.d.H. 
12. Y.v.d.H 
13. M.V. 
14. S.V. 
15. v.d.H-H. 
244 
-
155 
238 
667 
59,3 
703 
670 
514 
69,2 
69,0 
62.0 
136 
62,0 
92 
N 
N 
N 
1 
N 
N 
1 
t 
N 
N 
N 
N 
N 
N 
3685 
-
7532 
3165 
7752 
1721 
3428 
4606 
8823 
3639 
3496 
3326 
3830 
3404 
5217 
N 
1 
N 
N 
N 
N 
t 
t 
N 
N 
N 
N 
N 
1 
1200 N 
-
3683 t 
2462 t 
2439 N 
859 N 
1725 N 
1536 t 
2075 N 
352 N 
1522 N 
2609 N 
1600 N 
1628 N 
2699 N 
496 N 
-
785 1 
403 N 
579 N 
297 N 
382 N 
512 t 
373 N 
234 N 
225 N 
734 N 
568 N 
351 N 
1139 N 
2,9 
3.6 
1,3 
-
3,8 
3,3 
3,0 
3,6 
5,0 
3,5 
1,0 
-
2,1 
3,7 
2.1 
5,4 
0,4 
3,7 
8,6 
9,1 
0,3 
0,4 
2,2 
15,0 
1,5 
0,2 
0.3 
0,3 
3,9 
0.4 
1 increased; N normal values from [5,6]. 
normal values according to Paunier in infants and children (1 month-14 years) [11]. 
Ca 1.1 - 7.4 mg/kg.day 
Mg 0.9 - 5.2 mg/kg.day 
normal values according lo Ghazali and Barrait (1-11 years old) [12]. 
Ca 2.38 ± 0.66 SD mg/kg.day 
Mg 2.82 ± 0.78 SD mg/kg.day 
κ> 
patients before any form of treatment was given. All patients showed hypokalemic 
alkalosis and had a distinctly raised plasma renin activity (Fig. 1). Serum magnesium 
(normal values 0.70-1.04 mmol/1) was lowered in patient 10 to 15. 
The urinary excretion of the different prostaglandins PGEj, PGF^, 6 Keto-PGF1(1 
and TXB2 as well as the urinary excretion of magnesium and calcium is given in table 
II. Only in the minority of the patients an increased excretion of some of the 
prostaglandins was noted (Fig. 1). The urinary Mg excretion was normal in all 
patients. In 7 patients the calcium excretion was lower than 1,1 mg/kg.day, in 3 
patients the calcium excretion was higher than 7 mg/kg.day. 
MONONUCLEAR MAGNESIUM (ug/mg protein) • 
2 r 
1.5 
0.5 
А Д 
α · 
Φ Bartter Syndrom« A Qltelman S y n d r o m · U Uncertain 
0.2 0.4 0.6 0.8 1 1.2 
SERUM MAGNESIUM (mmol/l) 
ERYTHROCYTE MAGNESIUM (ug/gr. RBC) -
200 f-
150 
100 
50 
· · 
A A
 D 
* Bart ier Syndrom« A Qltelman Syndrom« Q Uncertain 
0.2 0.4 0.Θ 0.Θ 1 1.2 
SERUM MAGNESIUM (mmol/l) 
Figure 2. Relations between the serum magnesium level and the cellular content of magnesium in 
erythrocytes and mononuclear cells shows a significant positive correlation (r=0,76, p>0.01 and r=0.71, 
p>0.01 respectively). 
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Urinary 
Mg2*excretion mg/100ml GFR-1.73m2 
3.0 
2.0-
1.0-
uf Mg^ mg/100ml 
Figure 3. Ultrafillrable serum Mg concentrations are plotted against urinary Mg excretion. 
The area between the dotted lines represents the 95% confidence limiis according to Rude et al. [10]. 
The main results of the hypotonic saline infusion test are shown in table III. The distal 
chloride delivery was increased in two patients (5,7) (omitting the patients with 
diminished GFR). The percentage of the distal chloride load being reabsorbed distally 
was lowered in all patients without exception. This is in agreement with the limited 
dilution (Uosmol) obtained during the experimental procedure. The chloride data are 
preferred to the sodium data as these data do not take into account the sodium 
reabsorbed distally by exchange with potassium and hydrogen ion. In table III the 
values of the endogenous clearance of creatinine together with urinary concentrating 
capacity obtained after DDAVP are also presented. The clearance of creatinine was 
lowered in 5 patients (1, 3, 4, 6, 8). In five of the patients (number 7-10-11-12-15) a 
normal concentrating capacity was measured. A slightly decreased capacity was 
present in patients 6-13-14. 
The plasma renin activity [4], the prostaglandin excretion [5,6] and the DDAVP test 
[7] were performed according to previously reported methods. The study of the 
fractional clearances during hypotonic saline diuresis were based on the findings of 
Rodriguez-Soriano et al. [8]. The methods for extra- and intracellular magnesium are 
described earlier [9]. The renal magnesium threshold and tubular maximum for 
magnesium were done according to Rude et al. [10]. The normal values for the 
urinary excretion of calcium and magnesium are obtained from Paunier et al. [11] and 
Ghazali and Barratt [12]. 
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Table 3. Results of the hypotonic 
Initials 
1. B.B. 
2. B.R. 
3. A.T. 
4. G.M. 
5. N.J. 
6. M.L. 
7. A.S. 
8. Y.C. 
9. A.B. 
10. J.v.d.R. 
11. Cv.d.H. 
12. Y.v.d.H. 
13. S.V. 
14. M.V. 
15. M.V.H.-H. 
Normal 
values 
Uosmol 
mosmol/kg 
186 
-
I l l 
107 
146 
113 
121 
-
179 
73 
121 
-
113 
103 
, 93 
54.1 
± 13.3 
Ck 
ml/100mlGFR 
97 
-
41.9 
155.0 
128.3 
24.8 
46.5 
-
15.5 
34.1 
31.7 
-
83.2 
52.4 
21.0 
12.9 
± 5.2 
saline perfusion test, creatinine clearance and DDAVP test. 
C H20 + CCI 
mWOOml GFR 
20.6 
-
-
39.9 
25.2 
16.1 
36.2 
-
2.3 
16.7 
8.4 
-
10.1 
9.1 
6.0 
15.9 
± 2.6 
C H20 
C H20 
31.6 
-
55.0 
60.9 
46.9 
56.4 
50.3 
-
51.9 
70.9 
63.5 
. 
66.6 
68.8 
72.8 
86.7 
± 4 . 1 
IfUT** lUUvb 
+ CCI 
Qearance of 
creatinine 
т1/тіп.1,73 m2 
59 
86 
70 
42 
99 
41 
85 
18 
127 
80 
135 
116 
122 
120 
150 
so­
no 
Concentrating 
^ * m n f 4 Фчі 
capacity 
mosmol/kg 
377 
534 
445 
171 
509 
748 
1166 
300 
294 
1015 
1070 
980 
719 
802 
914 
Ì 807 
Statistical methods 
We used Spearman's rank correlation coefficients to detect relationships between 
different variables. Results were considered to be significant when p<0.05. 
RESULTS 
Six of the 15 studied patients had permanently a lowered serum magnesium level. 
These six patients had a normal glomerular filtration rate and a normal or slightly 
decreased concentration ability. 
One of other patients (number 2) had initially a normal serum magnesium level. A 
significant positive correlation was noted between the serum magnesium and 
potassium level (r=0.76, p<0.01). 
The results of the intracellular magnesium and potassium levels in mononuclear cells 
and erythrocytes are shown in table IV. Almost all values for intracellular magnesium 
in mononuclear cells were in the normal range. In these cells a positive correlation 
existed between the serum magnesium level and the concentration of magnesium only 
when the magnesium concentration was expressed in terms of cellular protein content 
(r= 0,71), ρ < 0,01) (fig. 2). 
Five patients had a lowered magnesium content in the erythrocytes. There was a 
significant positive correlation between the serum magnesium level and the 
intracellular concentration of magnesium in the erythrocytes (r= 0,76, ρ < 0.01)(fig. 
2). 
In two patients (number 11, 15) a lowered renal magnesium threshold was found 
together with a normal tubular maximum for magnesium (Fig. 3). 
DISCUSSION 
For the interpretation of the metabolic studies an adequate classification is required 
of the familial hypokalemia due to renal potassium loss. Bartter's syndrome is 
frequently confused with the syndrome of hypokalemia/hypomagnesemia first 
described by Gitelman et al. [13]. 
Classification of the patients 
Six out of 15 patients had a lowered serum magnesium level with a normal 
magnesium excretion pointing to a defect in magnesium reabsorption (number 10-15). 
These patients were asymptomatic with the exception of occasionally episodes of 
muscular weakness and tetany. Patient number 12, however, was severely handicapped 
by her disorder and unable to perform even light domestical work due to muscular 
weakness. After treatment with magnesium suppletion and amiloride a normal life 
became possible. 
In the six patients with Gitelman's syndrome the same abnormalities as in the 9 other 
patients were found for plasma renin activity, prostaglandin excretion, plasma 
potassium, chloride, and metabolic alkalosis. The distal chloride resorption defect 
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Table 4. Results of the intracellular concentration of Magnesium and Potassium together with main serum 
electrolytes at the time of investigation. 
Serum mo-Mg mo-K mo-prot mo-DNA er-Mg er-K 
Initials Mg Na К Cl Ca 
шшоІЛ fg/cell lig/mg jig/mg fg/cell Mg/mg Mg/mg fg/ccll pg/cell mg/gr mg/gr 
prol DNA prot D N A RBC RBC 
1. B.B. 
2. B.R. 
3. A.T. 
4. G.M. 
5. N.J. 
6. ML. 
7. A.S. 
8. Y.C. 
9. A.B. 
10. J.vd.R. 
11. C.v.d.H. 
12. Y.v.d.H. 
13. M.V. 
14. S.V. 
15. v.d.H-H. 
0,90 
0,63 
0,72 
0,89 
0,89 
0,77 
0,79 
1,04 
0,86 
0,63 
0,47 
0,47 
0,52 
0,67 
0,58 
range of normal 
values 
136 
142 
140 
139 
144 
138 
140 
134 
140 
142 
141 
-
137 
137 
139 
3,6 
3,3 
3,2 
3,4 
3,4 
3,4 
3,4 
3,7 
3,6 
3,2 
2,4 
2,5 
2,6 
2,5 
2,1 
105 
91 
96 
-
96 
103 
101 
92 
102 
103 
90 
-
102 
96 
95 
2,50 
2,60 
2,56 
2,52 
2,61 
2,45 
2,44 
2,72 
2,50 
2,39 
2,50 
-
2,50 
2,57 
2,46 
124 
132 
112 
141 
107 
53 
104 
110 
102 
55 
91 
96 
109 
115 
95 
71-
156 
1.41 
1.01 
1.03 
1.13 
1.29 
0,54 
1,75 
1.16 
1.09 
1.16 
0.83 
0.84 
0.95 
1.12 
0.94 
0.53-
1.83 
13.7 
19.8 
14.8 
15.4 
11.1 
5,7 
-
11.9 
11.4 
7.8 
12.3 
12.9 
10.4 
11.2 
11.7 
2.9-
23.3 
1459 
1684 
1553 
1714 
1326 
1264 
-
1482 
1229 
896 
1073 
1101 
1563 
1198 
1302 
787-
2668 
16.6 
12.9 
14.3 
13.7 
16.0 
12.9 
-
15.6 
13.1 
18.8 
9.8 
9.6 
13.7 
11.6 
13.0 
8.19-
20.7 
162 
253 
206 
186 
138 
135 
-
161 
137 
127 
146 
147 
149 
116 
161 
104-
334 
0,09 
0,131 
0,109 
0,125 
0,083 
0,098 
0,099 
0,095 
0,094 
0,050 
0,110 
0,115 
0,110 
0,100 
0.100 
0.054-
0.205 
9,0 
6,7 
7,5 
9,2 
9,6 
9,3 
-
9,1 
9,0 
7,1 
7,3 
7,5 
10,5 
10,3 
8,1 
5.2-
11.4 
178 
119 
172 
144 
146 
140 
125 
170 
146 
129 
120 
125 
106 
112 
120 
125-
193 
9.5 
8.4 
10.0 
9.1 
9.0 
-
-
9.5 
9.4 
8.7 
9.6 
8.1 
8.8 
7.3 
8.5 
8.2-
11.7 
mo = mononuclear cells. 
er = erythrocytes. 
Concentrating capacity (mosmol/kg ) 
1200 η 
1000-
800-
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¿oo-
200-
D 
X 
•Bartter sydrome 
* Gitelman syndrome 
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ι ι I 
D 
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с
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Figure 4. The concentrating capacity and the distal chloride transport measured during the hypotonic 
saline infusion test were not significantly correlated (r=0.41, p=0.18) (upper panel). 
Significant correlation was present between the concentrating capacity obtained after DDAVP and the 
urinary calcium excretion (r=-0.76) p<0.01) and serum magnesium concentration (r=-0.72> p<0.01) 
respectively (lower panel). 
X indicates clearance of creatinine < 80 ml/min.1.73 m2. 
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was milder. All six patients had a normal or slightly decreased concentrating capacity 
as measured by the DDAVP test. The urinary calcium excretion was either decreased 
or normal. It is striking that in one of siblings ( patient number 13) the urinary 
calcium excretion was lowered while in the other sibling (14) the calcium excretion 
was in the normal range. In both siblings the calcium excretion was repeatedly 
measured. All six patients had a normal glomerular filtration rate. 
Based on the criteria of distinctly decreased concentrating capacity, a normal or 
increased calcium excretion, a normal or decreased glomerular filtration rate and a 
normal serum magnesium, patients 1, 3, 4, 5, 8, 9 can be classified as Bartter's 
syndrome. For three patients the classification remains uncertain. 
Patients number 2 had a decreased calcium excretion. The glomerular filtration rate 
of this patient decreased progressively (31 ml/min/173 SA at the age of 16) and his 
serum magnesium became lowered since the age of 4 years. 
Patient number 6 had a slightly decreased concentrating capacity with a lowered 
calcium excretion and a decrease of the glomerular filtration rate at the age of 7 
years. Occasionally she has a lowered serum magnesium (0.65 mmol/1). 
Patient number 7 had a normal concentrating capacity, a lowered calcium excretion 
and a normal glomerular filtration rate. The serum magnesium level was repeatedly 
normal. 
Table V. Characteristics of Bartter's and Gitelman's syndrome. 
serum 
magnesium 
urinary excretion 
of calcium 
concentrating 
capacity 
glomerular filtration 
rate 
localisation of 
defect 
Bartler syndrome's 
almost always 
normal 
increased or 
normal 
decreased 
decreased (or declining) 
or normal 
thick ascending limb 
of loop of Henle 
(medullary part 
cortical part?) 
Gitelman syndrome's 
decreased 
decreased or 
normal 
normal or slightly 
decreased 
normal 
cortical portion of 
thick ascending limb 
and/or distal tubule 
It is possible to make a clear distinction between Bartter's syndrome and Gitelman's 
syndrome. There remain, however, patients with characteristics of both syndromes 
(table V). The presumed localisation of the defect in the distal nephron is different in 
both syndromes. 
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Based on the facts of a disturbance in chloride transport in the distal nephron and the 
decreased concentrating capacity a defect in the medullary part of the thick ascending 
limb of the loop of Henle is straight forward. It is difficult to make a definite 
conclusion about the contribution of the cortical part of the thick ascending limb of 
the loop of Henle. Each hypothesis is based on micropunction studies in animals. And 
this part of the nephron behaves differently in the rat and the mouse. In the rat the 
adenylcyclase system of medullary and cortical portions of the ascending limb are 
sensitive to ADH, glucagon and calcitonin. Only the cortical part is sensitive to PTH. 
In the mouse the cortical part is sensitive to all tested hormones. Whereas in the 
medullary part the adenyl cyclase system was only stimulated by ADH and glucagon. 
In the control situation in the mouse the calcium and magnesium resorption is almost 
limited to the cortical part of the ascending limb [14,15]. In the rat the calcium 
transport is passive in the medullary segments and probably active in the cortical 
segments [16]. It is thus quite possible that also the cortical part of the ascending limb 
of Henle is involved in the pathogenesis of Bartter's syndrome. 
Based on the fact that the concentrating ability of the patients with Gitelman's 
syndrome is normal or only slightly decreased together with a disturbance of chloride 
transport in the distal nephron excludes the medullary part of Henle's loop as 
localisation of the defect. A moderate concentrating defect can easily be explained by 
potassium depletion [17]. A defective functioning of the cortical ascending limb or 
early distal tubule or both can explain the pathogenesis of Gitelman's syndrome. 
The combination of hypocalciuria with increased renal magnesium loss was observed 
by us in patients with isolated renal magnesium loss [18] and in patients after the 
administration of cisplatin [19]. 
By applying the Bartoli technique [20] in 5 patients with Gitelman's syndrome, 
Rodriguez-Soriano et al. indicated the distal tubule as localisation of the defect [21]. 
By measuring the difference in the urine flow rate after and before furosemide 
administration during water diuresis, separate calculations of natriumchloride 
reabsorption by the loop of Henle and by the distal tubule can be performed. The 
small number of both patients and controls studied do not allow a definite conclusion. 
Both the free water formed by the loop of Henle and the free water formed by the 
distal tubule were lowered in Gitelman's syndrome but the difference was only 
significant for the distal tubule (5 patients versus 4 controls). 
In the future the molecular approach will afford the definite solution. 
If is confirmed that magnesium suppletion in patients with Gitelman's syndrome, 
normalises the urinary calcium excretion [22] we have only to explain a combined 
chloride and magnesium defect, both actively transported in the cortical part of the 
ascending thick limb of Henle. 
Magnesium metabolism 
In five out of seven patients with a lowered serum magnesium, the magnesium 
content of the erythrocytes was also decreased. In experimental studies in the dog the 
erythrocyte magnesium content behaved as a good indicator for body magnesium 
stores [23,24]. There is also evidence that mononuclear cell magnesium levels may 
reflect skeletal and cardiac muscle concentrations [25]. In a similar study in one 
129 
patient with Gitelman's syndrome Bianchetti et al. [26] found normal intracellular 
levels of magnesium in erythrocytes and lymphocytes. In four adult patients with 
Bartter's syndrome (or Gitelman's syndrome?) Rudin et al. [3] could not demonstrate 
a reduced magnesium content in the skeletal muscle specimens. All these results do 
not indicate a pronounced intracellular magnesium deficiency. 
An intracellular magnesium deficiency, however, may be more extensive in some 
exceptional cases such as the patient described by Cushner et al. [27] with a serum 
magnesium of 0.33 mmol/l. In such a situation supplementation of magnesium might 
induce a positive potassium balance. 
In earlier studies by Rodriguez-Soriano et al. [21] in children with Gitelman's 
syndrome, a lowered threshold for magnesium could be measured. This was confirmed 
by our studies in two patients. In addition a normal tubular maximum was present. 
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Chapter 10 
SUMMARY AND FINAL DISCUSSION 
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Magnesium deficiency has many different causes. The underlying pathophysiology is 
based on three different types of defects: lowered intake, disturbed intestinal 
resorption or decreased renal reabsorption [1]. 
The kidney is considered to be the key organ in the magnesium homeostasis [2]. After 
ultrafiltration in the glomerulus about 25% of the filtrated magnesium is reabsorbed 
in the proximal tubule and up to 65% is reabsorbed in the thick ascending limb of 
Henle, depending on the level of magnesium in the blood. In contrast with the total 
number of patients with renal magnesium loss, patients showing congenital 
impairment of renal magnesium reabsorption are rare [3]. Three different types of 
hereditary renal magnesium loss are distinguished by Rodriguez-Sariano [4]: isolated 
familial hypomagnesemia, familial hypokalemia-hypomagnesemia and familial 
hypomagnesemia-hypercalciuria (chapter 1). 
Isolated renal magnesium loss 
In chapter 2, two unrelated families with isolated renal magnesium loss are described 
showing an autosomal dominant mode of inheritance. No abnormalities were detected 
by conventional kidney function tests performed in both probands and by kidney 
biopsy in one. Magnesium infusion tests showed not only a lowered renal magnesium 
threshold but also a reduced tubular maximum for magnesium. With oral magnesium 
supplementation, we were unable to correct the lowered serum magnesium level. 
It is important to realise that renal magnesium reabsorption is not characterised by a 
tubular transport capacity as may be supposed at inspection of the data of the urinary 
excretion. In fact, micropuncture data during magnesium loading in the dog and rat 
reveal that in the proximal tuble net reabsorption of magnesium rose proportional to 
the increase in filtered load and increased initially in Henle's loop but fell with high 
plasma magnesium concentrations [5,6]. Little magnesium reabsorption was observed 
between distal collection site and final urine. 
When a normal level of ultrafiltrable magnesium was reached during the magnesium 
loading test in patients with renal magnesium loss, about half of the filtered 
magnesium was excreted in the urine. This indicates the ascending limb of Henle's 
loop as at least one of the localisations of disturbed magnesium transport. 
In all members of both families with hypomagnesemia, a lowered urinary excretion of 
calcium was noticed. As is discussed in chapter 9 about Bartter/Gitelman's syndrome, 
the cortical part of the ascending limb of Henle's loop should be involved. 
Isolated renal magnesium loss with autosomal recessive inheritance is described in two 
sisters in chapter 3. Magnesium infusion test in both girls revealed a lowered 
magnesium threshold and a normal tubular maximum. It is difficult to understand 
what is altered in the magnesium transport when only the threshold is lowered. In 
opposite to the autosomal dominant isolated renal magnesium loss, calcium excretion 
is normal in the autosomal recessive form. 
Prostaglandin excretion during hypomagnesemia 
Prostaglandin studies during magnesium depletion, meanly performed in rats [7,8], 
showed elevated plasma and tissue prostaglandin levels. In chapter 4 renal 
prostaglandin excretion in patients with isolated renal hypomagnesemia is presented. 
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Urinary excretion of prostaglandin E2, prostaglandin F^, 6-keto-prostaglandin F ^ 
and tromboxane B2 was in the normal range. Species differences, and different degree 
and duration of magnesium deficiency may exist. In contrast to potassium depletion, 
hypomagnesemia in humans does not stimulate the excretion of prostaglandins in the 
urine. 
INTRACELLULAR MAGNESIUM CONTENT 
Reference values in children 
In chapter 5 the reference values of serum magnesium concentration, as well as 
magnesium and potassium content in mononuclear cells and erythrocytes are 
presented. Samples were taken from cord blood and in children from infancy through 
adolescence. Differences between boys and girls were absent. Mononuclear 
magnesium content was independent of age and was within the adult range of values. 
No significant correlation between the serum magnesium level and the mononuclear 
magnesium content was shown. Mononuclear potassium also showed no age-related 
differences. A significant correlation between mononuclear magnesium and potassium 
content was observed; however this correlation was lower when magnesium and 
potassium contents were expressed in terms of protein content. 
The magnesium content of erythrocytes was significantly lower in cord blood and 
during the first month of live, compared with that at older ages and showed no 
significant correlation with the serum magnesium level. The lower magnesium content 
in the erythrocyte expressed per gram dry weight is related to the decreased number 
of erythrocytes per gram dry weight and thus a decreased cell membrane content per 
gram dry weight. About 6% of the erythrocyte magnesium content might be bound to 
the cell membranes [9]. 
The erythrocyte potassium concentration was independent of age and a low but 
significant correlation with erythrocyte magnesium content was noted. 
Intracellular magnesium content in patients with isolated renal magnesium loss 
In spite of remarkably lowered serum magnesium levels, mononuclear magnesium 
content was in the normal range in patients with isolated renal magnesium loss 
(chapter 4). Erythrocyte content of magnesium was lowered in 6 out of 12 patients 
and was in the low normal range in 4 others. A significant correlation between 
erythrocyte magnesium content and the serum magnesium level was noted in these 
patients. 
Studies in patients with Barrter/Gitelman's syndrome 
In chapter 9, patients with Banter's syndrome were distinguished from patients with 
Gitelman's syndrome based on the serum magnesium level, the urinary excretion of 
calcium, the concentrating ability and the glomerular filtration rate. In five of seven 
patients with a lowered serum magnesium level, a reduced magnesium content in the 
erythrocytes was observed. The erythrocyte magnesium content is considered to be a 
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good reflection of the body magnesium stores. 
Experimental magnesium depletion 
Experimental magnesium deficiency was induced in young adult beagles by magnesium 
deficient diet as described in chapter 6. A significant decrease of the magnesium 
content of muscle and mononuclear cells was not detected during and at the end of 
the magnesium deficiency, but the muscular magnesium content rose significantly after 
normalisation of the serum magnesium level. 
The serum magnesium concentration and both erythrocyte and bone magnesium 
content decreased significantly during and at the end of the magnesium deficiency 
period. A highly positive correlation coefficient for serum and erythrocyte magnesium 
was present and positive correlation was shown for erythrocyte and bone magnesium 
amounts. The wide range of the bone magnesium levels before the start of the 
magnesium deficient diet, indicates that individual measurements of the bone 
magnesium content have limited applicability for the detection of intracellular 
magnesium deficiency. There was a low correlation coefficient between serum 
magnesium and bone magnesium during magnesium depletion in the dog. 
This finding is in contrast with the data presented by Cohen and Kitzes [10] in 
humans; they found a very good correlation between the serum magnesium 
concentration and bone magnesium content. 
Erythrocyte magnesium content and serum magnesium showed a good correlation. 
After normalisation of the serum magnesium concentration the erythrocyte 
magnesium content rose significantly compared with the values at the end of the 
magnesium deficient period. The results of these experimental studies agree with 
those obtained in patients with renal magnesium loss. Erythrocyte magnesium levels 
are a better reflection of the body magnesium stores than mononuclear cells. This 
important place of the erythrocyte stimulated further studies of the metabolic active 
component of magnesium in the erythrocytes. After a short review of the literature, 
comment on the own obtained results will be made. 
MAGNESIUM TRANSPORT IN ERYTHROCYTES 
Magnesium influx 
Examinations of ^Mg uptake by red cells in several species revealed a very slow 
uptake in human erythrocytes but about ten times faster in rat, cat and dog red cells 
[11]. In human erythrocytes about 5% of the plasma ^Mg amount was exchanged for 
intra-erythrocyte magnesium in 5 hours [11]. Adsorption of magnesium to the external 
membrane of the erythrocyte should, however, be excluded. No uptake of ^Mg by 
human erythrocytes incubated 24 hours at 37° С was detected by Ginsburg et al. [12]. 
The explanation of this phenomenon is that the magnesium ion binds strongly 6 
molecules of water and exchanges this water very slowly [13] for polar groups in the 
channel wall in the membrane [14]. Since dehydration at a narrow region of the 
channel is the rate-limiting step in the passage of ions through the membrane, the low 
permeability of membranes for magnesium is not surprising [14]. It is suggested that 
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magnesium movements occurring in red cells will be in association with membrane 
protein [15]. 
Ginsburg et al. showed that magnesium content of human and rabbit erythrocytes in 
suspension increased as the reticulocyte count increased [12]. Recently in guinea pig 
reticulocytes and mature red cells Jelics et al. [16] detected a sharply decreased ATP 
concentration in mature red cells compared to reticulocytes, whereas the intracellular 
free magnesium concentration increased from 150 дтоі/і cell water in reticulocytes to 
250 дтоі/і cell water in mature red cells [16]. It was suggested that alterations in the 
kinetics of membrane ion transport systems, accompanying changes in cholesterol and 
phospholipid content, occur during maturation of the red cell [16]. In contrast to the 
lowered level of free intracellular magnesium, the total magnesium content is 
increased in the reticulocytes. A large amount of magnesium is bound to ATP and 
magnesium may also be bound to the ribosomes. 
Magnesium efflux 
The initial rate of magnesium efflux in fresh human erythrocytes incubated in Na+, 
K+-Ringer's medium was 7.3 ± 2.8 μπιοΐ/ΐ cells per hour (mean ± sd) [17]. Ludi and 
Schatzman [18] detected a Na+-stimulated maximal magnesium efflux of 4.6 ± 1.2 
μιηοΐ/ΐ cells per hour (mean ± sem) in unloaded human erythrocytes. The normal 
content of total magnesium in the erythrocyte is about 3 mmol/1 cell water. This 
means the about 0.2 per cent of the magnesium content is leaving the red blood cell 
per hour. 
In the last few years several papers characterising net magnesium efflux from 
magnesium loaded red cells were published [19-27]. In the magnesium loaded cells, 
however, the fluxes are much larger than in magnesium unloaded erythrocytes. A 
Na+-dependent and a Na+-independent magnesium efflux was demonstrated [21]. 
Na+-dependent magnesium efflux in rat and chicken erythrocytes was remarkably 
higher than Na+-independent efflux (5.7 and 4.2 times respectively) [24]. This is in 
contrast to loaded human red cells in which Na+-dependent magnesium efflux was 
0.16 mmol/1 cells per 30 min whereas Na+-independent magnesium efflux amounted 
0.89 mmol/1 cells per 30 min. [24]. The Na+-dependent magnesium efflux (in rat 
erythrocytes) only occurred at elevated intracellular magnesium amounts and stopped 
when the physiological magnesium content was reached. Magnesium efflux was 
specifically combined with the uptake of sodium at a stoichiometric ratio of 2Na+ : 
lMg2+, indicating electroneutral Na+/Mg2+ antiport. This Na+/Mg2+ antiport (in 
human and rat erythrocytes) is ATP dependent[ 19,27]. 
Na+-independent magnesium efflux in loaded human erythrocytes (about 90% of total 
net magnesium efflux) was considered to be dependent on net chloride efflux for 
charge compensation [23]. Both effluxes are inhibited by amiloride [25]. 
In magnesium loaded erythrocytes from magnesium deficient rats both Na+-dependent 
and Na+-independent magnesium efflux were increased by one third and it was 
suggested that increased affinity of the Na+/Mg2+ antiporter for intracellular 
magnesium caused the reduced intracellular magnesium concentration [26]. This efflux 
system is unaltered during maturation of erythrocytes [27]. 
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Ionized magnesium in erythrocytes; comment on the own obtained results 
Ionized magnesium concentration of human erythrocytes ([Mg2"1"],) is 0.55 ± 0.12 
mmol/1 cell water (chapter 8) measured with zeropoint titration. 3 1P Nuclear Magnetic 
Resonance (31P NMR) measurements of [Mg2"1"], revealed 0.20 ± 0.03 mmol/1 cell 
water. Variation in the dissociation constants markedly influences the results of 
intracellular magnesium when determined by the 3 1P NMR method. Lowered [Mg2"1"], 
was detected with 3 1P NMR in magnesium deficient dogs (chapter 7) and with both 
methods in patients with isolated renal magnesium loss (chapter 8). 
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Figure 1. Tentative model of magnesium transport systems in the human erythrocyte. Passive transport 
is denoted by dashed arrows, carrier-mediated transport by solid arrows and active transport processes 
are indicated by ihe — symbol. 
Erythrocyte [Mg2"1"], is below the electrochemical equilibrium 
In controls in which ultrafiltrable magnesium in plasma is 0.57 ± 0.04 mmol/1 
corresponding with an ionized magnesium concentration of β 0.5 mmol/1, a [Mg2*], of 
0.5 mmol/1 cell water is below the electrochemical equilibrium. With a membrane 
potential about 9 mV, inside (negative) the expected [Mg2"1"], should be « 1 mmol/1 
cell water in a situation where electrochemical equilibrium exists. In magnesium 
deficient rats [27] and dogs (chapter 7) ionized plasma magnesium is lowered just like 
[Mg2+] i and it is clear that in this situation, [Mg24], is also below the electrochemical 
equilibrium. Also in patients with isolated renal magnesium loss in which both plasma 
ionized magnesium and [Mg2"1"], are lowered, [Mg2+] j = 0.36 mM while [Mg2+], would 
be 0.59 mmol/1 cell water in the situation of electrochemical equilibrium (chapter 8). 
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SUGGESTIONS FOR FUTURE INVESTIGATIONS 
Perinatology 
Serum magnesium was significantly lower in cord blood than in samples from age 
groups older than one month. The concentration of magnesium in erythrocytes was 
also significantly lower in cord blood and during the first month of life compared to 
samples obtained in older children. Fetal plasma magnesium, however, exceeds that of 
the mother. Further studies are needed to measure not only the total magnesium 
concentration in serum but also the ultrafiltrable magnesium concentration as an 
indicator of ionized magnesium. The level of ionized magnesium in serum should be 
related to the parathormone level. 
The compartmentalisation of intracellular magnesium in the erythrocytes needs 
evaluation. What is the role of fetal haemoglobin? 
Erythrocytes 
Although still matter of debate, increasing evidence is available that magnesium 
exchange exists in erythrocytes under physiological conditions. In the magnesium 
deficient state in animals (rats and dogs) and humans [28], decreased values for 
ultrafiltrable magnesium in plasma and ionized and total magnesium in erythrocytes 
were observed. As presented in chapter 7 total erythrocyte magnesium decreased at a 
significant slower rate than ultrafiltrable plasma magnesium. The hypothesis that the 
quick fall of ultrafiltrable plasma magnesium (c.q. ionized magnesium) induces relative 
fast magnesium efflux out of the erythrocyte leading primarily to lowering of [Mg2"1"], 
followed by a drop of the total magnesium content of erythrocytes, needs 
experimental confirmation. 
Intracellular magnesium 
As fluorescent probes become available for the measurement of cytosolic free 
magnesium concentration, this method should be applied and compared with classical 
techniques. 
After the introduction of a new family of fluorescent calcium chelators by Grynkiewicz 
et al. [29], fluorinated NMR active dérivâtes of the chelator 0-aminophenol-N,N,O-
triacetic acid (APTRA) for the measurement of cytosolic free magnesium 
concentration were synthethised by Levy et al. [30]. The lipofylic acetomethylester of 
APTRA easily enters cells, including red blood cells, where intracellular cytosolic 
esterases cleave the ester, leaving the negatively hydrofylic charged, free acid trapped 
in the cell. 31F NMR studies of 4-methyl-5-fluoro-APTRA-loaded human erythrocytes 
revealed a basal ionized magnesium level of 0.25 mM. In cultured chick heart cells 
[Mg2+]i was 0.56 ± 0.03 mM. [31]. APTRA is insensitive to pH variations near the 
normal physiological range and 31F NMR studies revealed that both magnesium and 
calcium ions are bound by APTRA dérivâtes. However significant differences are 
present in the APTRA-magnesium and APTRA-calcium dissociation constants. For 
example for 4-methyl-5-fluoro APTRA the KdMg = 0.9 ± 0.1 mM and the Kd03 = 25 
± 10 mM at 37° С [30]. Moreover cytosolic calcium is present at a too low level to 
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significantly complex the chelator. 
Recently Raju et al. [32] modified APTRA to yield a fluorescent analogue which can 
be utilised as an intracellular probe for ionized magnesium. The chelator is called 
FURAPTRA or Mag-FURA-2 and has the desired sensitivity to cytosolic magnesium 
(KdMg = 1.5 mM) and is insensitive to pH and ionized calcium levels in the 
physiological range. After transport into the cell, the ester of FURAPTRA is 
hydrolysed and the free acid is than complexed with cytosolic ionized magnesium, 
resulting in excitation shift of this fluorescent indicator. The fluorescence changes of 
the absorption spectrum after magnesium complexation are similar to those observed 
on complexation of FURAPTRA by calcium ions, enabling the 'dual excitation ratio' 
method [29]. The advantage of this method is that measurement is independent of the 
absolute intracellular FURAPTRA concentration and that the calibration procedure is 
easier in comparison to a 'single wavelength' method. Two more advantages of 
FURAPTRA over the fluorinated NMR active dérivâtes of APTRA are that 
FURAPTRA can provide a better time resolution and is applicable when the total 
number of cells available for study is limited. In this way [Mg2-1 ]^, can be measured 
with a frequency of 5 per second by a photon-counting spectrotluorometer using, for 
instance, videoimaging. Incomplete hydrolysis of the acetoxymethyl ester of Indo-1 in 
epithelial cells [33], and incomplete deesterification of the acetoxymethyl ester of 
Fura-2 in human polymorphonuclear leukocytes [34], is reported. The same might 
apply to FURAPTRA. Partial hydrolysis products that fluoresce but do not bind with 
the same affinity as the free acid of Mag-FURA-2, can cause errors in the 
measurements of ionized magnesium. 
Several investigations of [Mg2*],, where FURAPTRA was used, were reported 
recently [35-37]. 
In isolated rat hepatocytes cytosolic [Mg2+]1 was 0.59 mM [32]. 
In cultured chicken heart cells basal cytosolic ionized magnesium averaged 0.48 ± 
0.03 mM. Perfusion with sodium-free solution increased [Mg2*], threefold [36]. The 
increase of [Mg2*], largely attenuated when calcium was removed from the sodium-
free perfusate, so it was concluded that a substantial part of the increase of [Mg24-], 
was dependent on an increase of intracellular ionized calcium. It was suggested that 
[Mg2"*"], is altered by calcium, most likely due to competition for intracellular binding 
sites [35]. 
In isolated beef heart mitochondria matrix, [Mg2"1"], was near 0.50 mM in the absence 
of external magnesium [36]. Matrix [Mg2"1"], increased when external magnesium 
increased. Matrix free [Mg2*], changed with changing ligand availability and such 
changes contribute to the regulation of [Mg2+]1-sensitive enzymes and transporters 
[36]. Addition of Pi decreases the free magnesium concentration. 
Intracellular free magnesium in cortical thick ascending limb cells is 0.53 ± 0.05 mM. 
About 2% of the total cell magnesium content should be free ionized magnesium [37]. 
Accordingly Mg2+ can enter the cell down the electrochemical gradient for magnesium 
is actively removed out of the cell. 
In culture techniques the magnesium concentration of the perfusate may alter [Mg2*],, 
so they are less suitable for research of magnesium deficiency in animals and humans. 
Direct measurement of [Mg2*], in erythrocytes or leucocytes with FURAPTRA may 
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provide a further step forward in magnesium research in the normal and magnesium 
deficient state. 
Study of the requirements of a correct measurement in these cells is necessary before 
they can be introduced into clinical medicine. It is an unique opportunity for a 
combination of basic and clinical research. 
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SAMENVATTING 
Hoewel Magnesium reeds door de mens in de middeleeuwen werd gebruikt als 
laxeermiddel, drong pas in de 20er en 30er jaren van deze eeuw het besef door dat 
magnesium een essentieel element is voor mens, dier en plant. Hoewel aanvankelijk 
getwijfeld werd aan het bestaan van een magnesium deficiëntie syndroom werd dit in 
1934 voor het eerst door Hirsfelder bij de mens beschreven. 
In hoofdstuk 1 worden naast de verschijnselen die zijn beschreven bij magnesium 
tekort, de ziekten en afwijkingen beschreven die (kunnen) lijden tot magnesium 
deficiëntie. De onderliggende pathofysiologie is gebaseerd op drie soorten afwijkingen: 
verminderde opname, gestoorde intestinale resorptie of verminderde renale 
reabsorptie. 
Het handhaven van een normale magnesium spiegel in het serum vindt plaats in de 
nier. Na glomerulaire filtratie wordt in de proximale tubulus ongeveer 25% 
teruggeresorbeerd en ± 65% in het opstijgende been van de lis van Henle. 
Afhankelijk van een (te) lage of (te) hoge serum Mg spiegel wordt in dit segment van 
de nier magnesium nagenoeg volledig gereabsorbeerd of slechts voor een (klein) 
gedeelte. Mg reabsorptie kan zowel transcellulair als paracellulair plaatsvinden. 
Geïsoleerd renaal magnesium verlies met autosomaal dominante overerving in twee 
families wordt in hoofdstuk 2 beschreven. Het is opvallend dat de personen die een 
sterk verlaagde serum Mg spiegel hebben geen verschijnselen hebben van magnesium 
deficiëntie. De opname van Mg in de darm is ongestoord. Met standaard nierfunctie 
onderzoek in beide probandi en in een nierbiopsie in een van beide, werden geen 
afwijkingen vastgesteld. Magnesium infusie studies tonen een verlaagde nierdrempel 
voor Mg aan en tevens een verlaagd tubulair maximum. Orale magnesium suppletie 
resulteerde niet in normaliseren van de serum magnesium spiegel. 
Men bedenke dat de renale magnesium reabsorptie niet adequaat kan worden 
uitgedrukt in termen van tubulaire transport capaciteit. Micropunctie studies bij de 
hond en de rat hebben aangetoond dat de netto reabsorptie in de proximale tubulus 
proportioneel toenam met de gefilterde hoeveelheid. In het opstijgende been van de 
lis van Henle daarentegen neemt de reabsorptie aanvankelijk toe bij stijging van de 
hoeveelheid gefilterd magnesium, maar neemt af als de serum magnesium spiegel 
verder stijgt. Slechts geringe magnesium reabsorptie werd vastgesteld in de distale 
tubulus en de verzamelbuizen. 
Als tijdens de magnesium infusie test bij de patiënten een normale ultrafiltrabele Mg 
spiegel in serum wordt bereikt, wordt ongeveer de helft van het gefilterde magnesium 
uitgescheiden in de urine. Dit betekent dat in ieder geval het magnesium transport in 
het opstijgende been van de lis van Henle is gestoord. 
Alle personen met hypomagnesiemie hadden een verlaagde calcium uitscheiding in de 
urine. Zoals ook in hoofdstuk 9 over het Bartter/Gitelman syndroom wordt besproken, 
ligt het voor de hand dat het corticale deel van het opstijgende been van de lis van 
Henle hierin is betrokken. 
Een familie met autosomaal recessief overervend renaal magnesium verlies wordt 
beschreven in hoofdstuk 3. Magnesium infusie studies tonen een verlaagde 
nierdrempel voor magnesium aan met een normaal renaal tubulair maximum. 
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De stoornis die ten grondslag ligt aan een uitsluitend verlaagde nierdrempel voor 
magnesium is niet goed te begrijpen In tegenstelling tot de autosomaal dominante 
vorm van renaal magnesium verhes, wordt bij de recessieve vorm een normale 
calcium uitschelding in de urine waargenomen. 
Uit dierexperimenteel onderzoek blijkt dat tijdens magnesium deficiëntie een 
verhoogd gehalte aan Prostaglandines in plasma en weefsels wordt gevonden. Bij 
personen met geïsoleerd renaal magnesium verlies werd daarentegen een normale 
excretie van P G F ^ PGEj, Tromboxane en 6-keto-PGFI(I in de urine vastgesteld 
(hoofdstuk 4). Verschillen tussen species en een verschil in de duur en/of ernst van de 
magnesium deficiëntie zouden hebben kunnen bestaan. In tegenstelling tot kalium de-
pletie, leidt hypomagnesiemie bij de mens niet tot een verhoogde uitscheiding van 
Prostaglandines in de urine. 
De referentie waarden voor Mg in serum, mononucléaire cellen en erytrocyten 
worden beschreven in hoofdstuk 5. Het gehalte van magnesium in mononucléaire 
cellen is niet verschillend in navelstrengbloed, bij zuigelingen en bij kinderen tot 16 
jaar en ligt binnen de volwassen grenswaarden Er werd geen correlatie tussen de 
serum magnesium spiegel en het magnesium gehalte in mononucléaire cellen 
waargenomen. Het kalium gehalte in mononucléaire cellen vertoonde geen verschillen 
met de leeftijd. Er bestond een significante correlatie tussen het magnesium en kalium 
gehalte in mononucléaire cellen, maar deze correlatie was lager als de magnesium en 
kalium gehaltes werden uitgedrukt op basis van het eiwit gehalte. 
Het serum Mg gehalte in navelstrengbloed is gedurende de eerst levensmaand lager 
dan daarna 
In de erytrocyten in navelstrengbloed en gedurende de eerste maand postpartum is 
het magnesium gehalte lager dan bij de volwassene, daarna tussen de leeftijd van 1 en 
6 maanden wordt een sterke stijging gezien tot volwassen waardes. 
De kalium concentratie in erytrocyten is leeftijds on-afhankelijk en vertoont een lage 
maar significante correlatie met het magnesium gehalte. 
Ondanks de duidelijk verlaagde serum magnesium waarden bij de patiënten met 
geïsoleerd renaal magnesium verlies, ligt het mononucleair magnesium gehalte bij hen 
binnen de normaal waarden (hoofdstuk 4). In de erytrocyten is het magnesium gehalte 
verlaagd bij 6 van 12 patiënten en is laag normaal bij 4 anderen. Er werd een 
significante correlatie tussen magnesium gehaltes in serum en rode bloed cellen 
vastgesteld 
In hoofdstuk 9 wordt een poging ondernomen patiënten met het Bartter syndroom te 
onderscheiden van hen met het Gitelman syndroom, op grond van hun serum 
magnesium spiegel, de uitscheiding van calcium in de urine, het concentrerend 
vermogen van de nier en de glomerulaire filtratie snelheid In vijf van zeven patiënten 
met een verlaagde serum magnesium concentratie wordt een verlaagd magnesium 
gehalte in de erytrocyten waargenomen. Het erytrocytaire magnesium gehalte wordt 
beschouwd als een goede weerspiegeling de totale hchaams magnesium voorraad 
Uit dierexperimenteel onderzoek bij de hond, beschreven in hoofdstuk 6, komt naar 
voren dat tijdens magnesium deficiëntie geen daling van het mononucleair- en spier 
magnesium wordt waargenomen, ondanks langdurig sterk verlaagde serum magnesium 
concentraties. Vijf van de tien honden vertoonden een betrekkelijk laag bot 
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magnesium gehalte voorafgaand aan de proef ondanks normale serum spiegels. Bij 
deze honden werd nauwelijks of geen daling van het bot magnesium vastgesteld 
tijdens de magnesium deficiëntie periode. Toch waren de bot- en erytrocyten 
magnesium gehaltes positief gecorreleerd. Individuele meetingen van het magnesium 
gehalte in bot hebben een beperkte toepasbaarheid voor de detectie van magnesium 
deficiëntie. 
Het magnesium gehalte in rode bloedcellen en de serum magnesium concentratie zijn 
sterk gecorreleerd. Na herstel van de serum magnesium spiegel stijgt het erytrocytaire 
magnesium gehalte in vergelijking tot het einde van de magnesium depletie periode. 
Deze waarnemingen komen overeen met hetgeen werd waargenomen bij patiënten 
met renaal magnesium verlies. Geconcludeerd werd dat het erythrocytaire magnesium-
gehalte een betere parameter is voor het aantonen van magnesium deficiëntie dan dat 
in mononucléaire cellen. De belangrijke plaats die de erytrocyten innemen leidden tot 
nader onderzoek naar de metabool actieve vorm van magnesium gehalte in de rode 
bloed cellen; het geïoniseerde magnesium. 
In hoofdstuk 8 worden 31P Nuclear Magnetic Resonanace (31P NMR) en nulpunt 
titratie als methoden voor het meten van vrij geïoniseerd intracelluliar magnesium 
beschreven bij 14 gezonde controle personen en 7 personen met erfelijk renaal 
magnesium verlies. De intracellulaire geïoniseerde magnesium concentratie in humane 
erytrocyten bedraagt 0.55 ± 0.12 mmol/1 cel water, gemeten met nulpunt titratie. 31P 
NMR metingen van [Mg24-], leverden 0.20 ± 0.03 mmol/I cel water op. Variatie in de 
verschillende dissociatie constanten beïnvloedden het resultaat van de [Mg2+]1 meting 
met 31P NMR sterk. Een verlaagde [Mg2+]j werd vastgesteld met 31P NMR in 
magnesium deficiëntie honden (hoofdstuk 7) en met beide methoden bij patiënten 
met geïsoleerd renaal magnesium verlies (hoofdstuk 8). 
De ultrafiltrabele magnesium concentratie in plasma bedraagt 0.57 ± 0.04 mmol/1 bij 
controle personen; dit komt overeen met een geïoniseerd magnesium concentratie van 
ongeveer 0.50 mmol/1, terwijl [Mg2"1-], in erytrocyten 0.50 mmol/1 cel water is. Dit is 
beduidend lager dan de concentratie die er zou bestaan in geval van electrochemisch 
evenwicht. Met een membraan potentiaal die -9 mV binnen in de erytrocyt is, 
bedraagt de met behulp van de wet van Nernst berekende [Mg2"1"], ± 1 mmol/1 cel 
water indien er electrochemisch evenwicht zou bestaan. Bij patiënten met geïsoleerd 
renaal magnesium verlies bij wie een verlaagde concentratie van geïoniseerd 
magnesium in het plasma bestaat en [Mg2" ]^, eveneens verlaagd is ( 0.36 mmol/1 cel 
water), terwijl [Mg2"1"], 0.59 mmol/1 cel water zou moeten bedragen indien er sprake 
zou zijn van electrochemisch evenwicht. 
Goede verwachtingen worden uitgesproken van het aanwenden van FURAPTRA voor 
het meten van de cytoplasmatische geïoniseerde magnesium concentratie. 
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DANKWOORD 
Een proefschrift kan alleen tot stand komen met behulp van een niet onaanzienlijk 
aantal personen; zo ook in het onderhavige geval. 
Bijzondere dank gaat uit naar de patiënten en hun familieleden. Door hun bereidheid 
en belangeloze medewerking aan grote delen van dit onderzoek kon een wezenlijke 
verbreding in de kennis van het magnesium metabolisme worden verkregen. 
Prof. L.A.H. Monnens; beste Leo, door je unieke manier van begeleiden van het 
onderzoek maar ook je visie op wetenschap en patiëntenzorg werden de afgelopen 
jaren niet alleen leerzaam maar ook heel boeiend. Met dit proefschrift is een klein 
deel van de wens die je vele jaren geleden in de status van een patiënt schreef, 
verwezenlijkt. 
Dr. J.L. Willems; beste Hans, je betrokkenheid bij het onderzoek en je kalme 
optimistische benadering van onze analytische problemen hebben bij mij de stellige 
overtuiging doen postvatten dat er geen noot zo hard is of hij kan gekraakt worden, 
als maar gezocht wordt naar de juiste techniek. 
Mevr. G.M. Vogels-Mentink; beste Trude, zonder jou zou dit proefschrift niet zijn 
voltooid. Je volhardende, kritische en nauwkeurige houding tijdens het opstarten van 
de methoden zijn van zeer grote waarde geweest. Met veel genoegen denk ik terug 
aan het werk in het laboratorium. 
Prof. С ν. Os, Dr. R. Bindeis en Dr. P. Vis wil ik graag bedanken voor hun kritische 
en stimulerende bijdragen aan de discussie omtrent geïoniseerd magnesium en de 
intracellulaire transportprocessen. 
Prof. C. Hilbers, J.J.M. Joordens, Dr. G. Rijksen en Dr. R. Ouwerkerk ben ik zeer 
erkentelijk voor hun bijdrage bij het opstarten en uitvoeren van de 31P NMR metin-
gen. 
Aan de dierexperimenten hebben Albert Peters, Leo Jansen, Theo Arts, Ton Peters 
en Fred Philipsen, allen medewerkers van het Centraal Dieren Laboratorium (hoofd: 
Prof.Dr. W.J.I. v.d. Gulden, Dr. J. Koopman) een onontbeerlijke bijdrage geleverd. 
Theo de Boo en Wim Lemmens namen de statistische bewerking van de onderzoeks-
resultaten voor hun rekening en leverden een significante bijdrage aan de discussie 
omtrent de uitkomst. 
Cees Nicolasen verzorgde vele van de tekeningen. 
De staf en medewerkers van het Centraal Klinisch Chemisch Laboratorium en het 
Laboratorium Kindergeneeskunde en Neurologie verleenden ons gastvrij onderdak 
tijdens het onderzoek en verrichtten vele hand- en spandiensten. 
Vele medewerkers en medewerksters van de kinderkliniek hebben bijdragen geleverd 
aan de uitvoering van de magnesium titratie en resorptietesten evenals de selectie van 
patiënten voor de referentiewaarden. 
De leden van de secretariële groep Kindergeneeskunde evenals Jeroen Hopman 
leverden ondersteuning in de verschillende fasen van voorbereiding en afwerking van 
dit proefschrift. 
Mijn collegae neonatologen dank ik voor hun flexibiliteit en bereidheid taken over te 
nemen tijdens de periode van het onderzoek en op schrift zetten van de resultaten. 
Beste Lya; "zonder woorden" is veelzeggend. 
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Het is helaas onmogelijk ieder die een bijdrage leverde aan het tot stand komen van 
dit proefschrift hier te noemen; ook zij die niet werden vermeld dank ik hartelijk. 
Niet in de laatste plaats ben ik allen die een bijdrage leverden aan mijn medische 
"opvoeding", zeer erkentelijk. 
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CURRICULUM ГГАЕ 
De auteur van dit proefschrift werd op 31 januari 1951 te Dinxperlo geboren. 
In 1967 behaalde hij het MULO A diploma aan de RK ULO school te Silvolde, 
gevolgd door het HBS-B diploma aan het Sint Ludgercollege te Doetinchem in 1970. 
De studie geneeskunde aan de Katholieke Universiteit Nijmegen werd in 1979 
afgesloten met de bevordering tot arts. 
Daarna was de auteur gedurende een jaar als arts-assistent kindergeneeskunde 
werkzaam in de praktijk van A.A.J. Broekman en J. Vonk, kinderartsen, Juliana 
Ziekenhuis respectievelijk St. Josef Ziekenhuis te Zaandam. 
Van januari 1981 tot 1985 werd de opleiding tot kinderarts gevolgd in het St. Rad­
boud Ziekenhuis te Nijmegen (Opleiders: Prof. Dr. E.D.A.M. Schretlen en Prof. Dr. 
G.B.A. Stoelinga). 
Een fellowship neonatologie werd vervuld van 1985 tot 1987 op de subafdeling 
neonatologie van het St. Radboud Ziekenhuis te Nijmegen (hoofd: Dr. J.M. Boon). 
Sindsdien is de auteur als kinderarts/neonatoloog verbonden aan laatst genoemde 
afdeling. 
De auteur is gehuwd met Lya Boere en samen hebben zij drie dochters; Leontien, 
Elisabeth en Barbara. 
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STELLINGEN 
I 
Een verlaagde concentratie van magnesium in het serum gaat niet gepaard met een 
verlaging van het totale magnesium gehalte in mononucléaire cellen. 
Dit proefschrift. 
II 
Het totale magnesium gehalte van erythrocyten is een betere weerspiegeling van het 
lichaamsmagnesium dan dit gehalte in de mononucléaire cel. 
Dit proefschrift. 
III 
Het is met de huidige kennis niet steeds mogelijk het syndroom van Bartter te 
onderscheiden van het syndroom van Gitelman. 
Dit proefschrift. 
IV 
Magnesium toediening aan patiënten met een vers hartinfarct leidt tot een significant 
hogere overleving en berust zeer waarschijnlijk op een farmacologisch effect. 
M. Schechter. Magnesium-Bulletin. 1990;12:1-5. 
V 
Bij een eenzijdige longagenesie, welke gepaard gaat met expiratoire belemmering, 
dient ernstig rekening te worden gehouden met het bestaan van een tracheastenose. 
T. Weber et al. Ann. Surg. 1991; 213: 70-74. 
VI 
Een uitgebreide deletie van het collageen 4a5-gen bij lijders aan het syndroom van 
Alport, predisponeert tot het ontstaan van een anti-GBM nefritis na transplantatie. 
Alport workshop Oulu 1991. 
VII 
Bij het berekenen van het alveolair-arterieel zuurstof verschil (AaDC^) dient men te 
beseffen dat het fysiologisch correcter is het eind-expiratoire C02-gehalte in de 
formule in te vullen in plaats van de arterïele C02-spanning. 
IX 
De resultaten van de toediening van exogeen surfactant aan prematuren met het 
"Respiratory Distress Syndrome" zijn zo evident dat deze medicatie niet meer kan 
worden onthouden, ondanks de te verwachten budgettaire problemen. 
X 
Bij kinderen met cataract en chronische diarree moet cerebrotendineuze Xanthomato­
se (СГХ), middels bepaling van gal-alcoholen in de urine, worden uitgesloten. 
J.R.M. Cruysberg et al. Am. J. Ophtalmol. 1991; 112: in press. 
XI 
De ontrafeling van de moleculaire basis van osteogenesis imperfecta begint het 
mogelijk te maken genotype en phenotype te correleren. 
P.H. Byers et al. J. Med. Genet. 1991; 28: 433-443. 
XII 
De beste manier om tijdschriften op het gebied van de kindergeneeskunde in 
ongekreukte toestand te kunnen bewaren, is ze op te bergen in een bibliotheek op 
afstand. 
XIII 
Het ontbreken van (voldoende) facultaire erkenning voor het klinisch chemisch 
vakgebied leidt op termijn tot een daling van de kwaliteit van de klinisch chemische 
dienstverlening ook in niet academische ziekenhuizen. 
XIV 
Voor diegenen die een (huwelijk)relatie aangaan met een medicus(m/v) is Hall's 
artikel "Medical marriage: no bed of roses" aanbevolen literatuur. 
A. Hall. B.M.J. 1988; 296: 152-153. 


